Prison needle exchange. by Long, Jean
The Mid-Term Review1 of the National Drugs Strategy 2001–2008,
published on 2 June 2005, recommends a number of additions and
amendments to the existing Strategy, including making
rehabilitation a new, ‘fifth’ pillar of the Strategy. The Steering Group
that oversaw the Review, and the extensive consultation process on
which it is based, found that the aims and objectives of the Strategy
are fundamentally sound. While what has been achieved varies from
action to action, progress has been made across the four pillars of
supply reduction, prevention, treatment and research, and in the co-
ordination of the institutional structures of the Strategy.
The Review recommends the addition of eight new actions, the
replacement of ten of the existing actions and amendments to a
further seven. It also recommends revisions to the Strategy’s key
performance indicators, reflecting new developments and data
availability. The recommendations serve to ‘re-focus and re-
energise’ the Strategy in the remaining period up to 2008.
Under the supply reduction pillar the Review recommendations include:
■ a new action dealing with specialist training in drug-related issues for the judiciary;
■ the replacement of an existing action to provide additional Garda resources to community
policing in local drugs task force (LDTF) areas;
■ the replacement of an existing action to allow for the extension of community policing fora to
all LDTF areas and to other areas experiencing drug problems.
Under the prevention pillar the Review recommendations include:
■ two new actions to cover the introduction of prevention education as part of the curriculum for
student teachers and the further strengthening of the role of the Home School Community
Liaison Scheme, particularly with respect to families with drug problems;
■ the replacement of an existing action to allow for the introduction of substance use policies in
all LDTF area schools, with a mechanism to monitor their development;
■ the replacement of an existing action to make preventative information more easily accessible to
parents and families;
■ amendments to four other existing actions.
Under the treatment pillar the Review recommendations include:
■ a new action making rehabilitation the fifth pillar of the Strategy and establishing a working
group to develop an integrated rehabilitation provision;
■ a new action to carry out an audit of the current availability of treatment options, including an
assessment of treatment needs;
■ the replacement of an existing action to allow for the full implementation of the guidelines
agreed by the Working Group on treatment for those under 18 years;
■ the replacement of an existing action to allow for the expansion of the provision of needle
exchange and related harm reduction services;
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■ the replacement of an existing action to allow
for an increase in the number of general
practitioners and pharmacists participating in
the methadone protocol;
■ amendments to two existing actions, one
which sets the maximum waiting period for
treatment to one month following assessment,
and the other which increases the availability
and range of treatment options, particularly in
relation to ploy-drug use.
Under the research pillar the Review
recommendations include:
■ two new actions establishing a process to
monitor the implementation of the
recommendations arising from the reports of
the National Advisory Committee on Drugs
(NACD) and the development of the Central
Treatment List by providing further
information regarding entry and re-entry of
opiate users to methadone treatment and the
length of time in treatment.
The Review acknowledges the important
preventative and support roles played by families.
It also recognises the difficulties faced by family
support services arising from uncertainty around
their role in dealing with families, lack of skills and
inadequate support.   These problems were
highlighted in a recent NACD report.  The review
recommends that the provision of family support
services should be prioritised and endorses the
recommendations of the NACD report, namely:
■ enable services to respond to the needs of
families through increased support and
training;
■ strengthen interagency links and networks by
building knowledge of local issues;
■ develop relevant monitoring and evaluation
tools to measure effectiveness of services.
An important factor affecting the level of progress
on actions is the extent of multi-agency involvement
required. There was strong support for the
partnership approach to the Strategy throughout
the consultation process, but there are certain gaps
and ill-defined roles which impact on the
collaboration between the multiple statutory
agencies, service providers and community and
voluntary groups involved in delivering the Strategy.
The Review recommends a number of changes to
the composition of the National Drugs Strategy
Team (NDST) and the Inter-Departmental Group
(IDG), which, along with the Cabinet Committee on
Social Inclusion, comprise the institutional structure
overseeing the implementation of the Strategy.
These recommendations include greater
participation from the community and voluntary
sector to represent the interests of the local and
regional drugs task forces. The Review also
recommends that the decision-making authority of
the IDG be strengthened and that it should include
representation from a number of statutory agencies.
This would assist the IDG in fulfilling the role
envisaged for it in the Strategy as an advisory body
to the Cabinet Committee on Social Inclusion.
While acknowledging that alcohol and drug misuse
are two separate policy areas, the Review
recognises the need to develop better linkages and
co-ordination between the two areas at policy and
operational levels. The Review recommends the
setting up of a working group involving key
stakeholders of both the alcohol and drugs area to
explore the potential for better co-operation
between the two areas and how synergies could
be improved. (Brian Galvin)
1. Steering Group for the Mid-Term Review of the National
Drugs Strategy (2005) Mid-term review of the National
Drugs Strategy 2001–2008. Dublin: Department of
Community, Rural and Gaeltacht Affairs.
National Drugs Strategy (continued)contents
The Pompidou Group’s European
Prevention Prize 2006
The Pompidou Group’s European Prevention Prize
is awarded annually to active youth drug
prevention projects that are currently functioning
in Pompidou Group member states.1 Its objective is
to recognise the importance of active youth
participation in drug prevention. Up to three youth
projects will each receive a monetary prize worth
€2,000. One of the eligibility criteria for the prize
is that young people, under the age of 25 years,
must be involved in the work of the drug
prevention project. The entries will be judged by a
jury comprising young people from the
Netherlands, Norway, Romania, the Russian
Federation, Turkey and the United Kingdom. The
jury will be supported by an advisory group of
adult drug professionals from Germany and the
United Kingdom. (Hamish Sinclair)
1. Member states of the Pompidou Group are: Austria,
Azerbaijan, Belgium, Bulgaria, Croatia, Cyprus, Czech
Republic, Denmark, Estonia, Finland, France, Germany, Greece,
Hungary, Iceland, Ireland, Italy, Liechtenstein, Lithuania,
Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
Russian Federation, San Marino, Slovak Republic, Slovenia,
Spain, Sweden, Switzerland, Turkey and the United Kingdom.
Applications must be submitted to the Secretariat 
of the Pompidou Group before 1 October 2005. 
Further details, including an application form, 
can be obtained from the Pompidou Group at
www.coe.int/T/DG3/Pompidou/Default_en.asp
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The EU Action Plan on Drugs 2005–2008 (COM [2005] 45 final)
is due to be adopted by the European Council in June 2005. It
identifies 61 actions to be taken over the next four years in
pursuit of the EU Drugs Strategy 2005–2012, which was
outlined in issue 13 of Drugnet Ireland. The actions are to be
undertaken variously by the EU institutions and special agencies
or by member states. Actions with implications for Ireland’s
National Drugs Strategy, which is coterminous with the EU
Action Plan, are outlined below. 
Co-ordination
In its evaluation of the 2000–2004 EU drugs strategy and action
plan on drugs (COM [2004] 707 final), the European
Commission concluded that civil society had not been regularly
consulted on drugs policy at either national or EU level. To
counter this perceived weakness, the new Action Plan identifies
two steps, including the issuing of a Green Paper by the
Commission in 2006 on ways to co-operate effectively with civil
society, and a report on the outcome of national-level
consultations on the drugs issue in 2008 by member states to
the Horizontal Drugs Group (HDG), which comprises
representatives of the member states and the European
Commission and reports to the European Council. Ireland’s Mid-
Term Review (MTR) of the National Drugs Strategy recommends
strengthening the representation of the voluntary and
community sectors on the two policy co-ordinating mechanisms
– the Inter-Departmental Group and the National Drugs
Strategy Team.
Demand reduction
The European Commission’s final evaluation of the EU Drugs
Strategy 2000–2004 also found that there was no strong evidence
that the rate of drug use prevalence in the EU had declined. To
strengthen the effectiveness of prevention initiatives, the Action
Plan calls on member states to (1) ensure that by 2007
comprehensive prevention programmes covering both licit and
illicit drugs as well as poly-drug use are included in school curricula
or are implemented as widely as possible, and (2) develop and
improve prevention programmes for specific target groups (e.g.
families at risk, ‘school drop outs’) and specific settings (e.g. drugs
and driving, drugs in the work place, drugs in recreational
settings). The MTR makes several recommendations with respect
to strengthening the effectiveness of prevention programmes and
targeting specific groups. With respect to specific settings, by 2008
the European Commission will complete a study on the influence
of alcohol, drugs and medicines on driving, and member states
will report to the HDG on the coverage of drug programmes in
the workplace.
Some eleven actions relating to treatment, harm reduction,
rehabilitation and social reintegration are listed in the Action
Plan. For example:
■ Member states are to improve early detection of risk factors
and intervention by providing appropriate training for
professionals who come in contact with potential drug users
■ Member states are to improve the availability of, and
access to, targeted and diversified treatment, rehabilitation
and social reintegration services. Concurrently, by 2007,
the European Commission is to prepare a proposal for an
EU agreement on minimum standards on drug treatment.
■ In respect of drugs in prisons, by 2007 the European
Commission is to prepare a proposal for a Council
recommendation regarding the development of prevention,
treatment and harm reduction services for people in prison,
reintegration services on release from prison and methods to
monitor and analyse drug use among prisoners. By 2008
member states are to report to the HDG on the progress they
have made in developing and using alternatives to prison for
drug addicts who have committed drug-related offences. 
■ Member states are called on to improve access to services
for the prevention and treatment of infectious diseases and
drug-related health and social damage, by ensuring access
for addicts to services designed to reduce risks; by
implementing comprehensive programmes on HIV/AIDS,
HCV, and other blood-borne diseases that include
vulnerable groups; and by identifying the reduction of
drug-related deaths as a specific target at all levels, and
designing interventions specifically to reduce the number
of deaths.
Supply reduction
The European Commission’s evaluation of the previous EU drugs
strategy found that there was no significant reduction in the
availability of drugs in the EU. The Action Plan identifies some
eleven actions intended to strengthen EU law enforcement co-
operation. At strategic level, the actions include a number of
research and information- and data-gathering initiatives on
various aspects of drug-related crime, including a study of best
practice in the establishment of a joint operational fund, to be
financed from the confiscation of assets earned through drug
production and trafficking.
At operational level the Action Plan calls for joint law
enforcement co-operation, including targeting money
laundering; fighting international organised drug production and
trafficking; combating serious criminal activity in the field of
precursor chemical diversion, and preventing the diversion of
precursors, particularly synthetic precursors imported into the EU.
Information, research and evaluation
In the area of information, member states are to participate in
fully implementing and fine-tuning the five key epidemiological
indicators, and in developing estimates of direct and indirect
expenditures on drugs, including law enforcement, drug-related
health and social issues and international co-operation. In 2007
the European Commission is to bring forward a proposal for an
agreement on EU guidelines and mechanisms for detecting,
monitoring and responding to emerging trends. With regard to
research, the European Commission is to promote research on
biomedical, psychosocial and other factors behind drug use and
encourage networks of research excellence for the optimal use
of resources and effective dissemination of results. (Brigid Pike)
EU Action Plan on Drugs 2005–2008
4drugnet
IRELAND
The 10th issue of Hyper appeared in Spring 2005.
Published by Soilse, the Health Service Executive’s
Addiction and Rehabilitation and Training Centre,
Hyper is produced largely by participants in the
Soilse drug rehabilitation programme, i.e. young
people aged between 18 and 25 years.
Since it first appeared in 1999,1 Hyper has carried
information features, and also personal stories and
poems by Soilse participants about their
experiences with drugs and drug addiction.
Respect – the means by which people attach a
social value to other people, or have a social value
attached to themselves – figures regularly in these
contributors’ stories.2
In post-industrial societies respect is a valued
commodity. In modern Ireland it has been
identified as one of the four ‘foundational
objectives’ to pursue if all members of Irish society
are to enjoy equality.3 Contributors to the latest
issue of Hyper reveal how complex the process of
acquiring or losing respect can be.4
Contributor David describes how his desire for
respect was a factor in his starting to use drugs at
the age of 11 or 12: ‘My family was a mess and
school was a joke. I was young with loads of
potential but craved the wrong things. I wanted
respect and hung around with the big boys on the
corners, doing all the stuff they were into –
robbing, mischief and taking drink and drugs.’
Another contributor, Daniel, delves further:
Most addicts would say they always felt
apart from everything, that no matter what
the circumstances were, they did not feel
they fit in. … How does a person fill this
void? We will look for excitement because
in this we may feel we belong. We will see
the drug scene as a group of people that in
our eyes look as one, where everyone is
loved, needed and wanted. This is where
the drug culture holds its power. To
someone who is looking for belonging, the
drug culture is a community.
Daniel’s explanation echoes that given in Becker’s
classic study of marijuana users in 1950s Chicago.5
The marijuana users gradually shifted their moral
allegiance, and their search for respect, from the
wider society to the drug-using network in which
they found themselves accepted. 
Becker also observed how drug users frequently
attempted to cure themselves of their addiction
and that the motivation was to show non-addicts,
whose opinions they respected, that they were not
as bad as they were thought to be. To their
dismay, however, they found that people still
viewed them as ‘junkies’, still stigmatised them,
still disrespected them. Contributors to Hyper who
are on methadone treatment describe a similar
experience. For example:
Derek: ‘There’s a stigma with ignorant people.
They don’t understand what methadone is.
… They view it as drugs instead of
stabilisation. You’re still viewed as a junkie.
Alcohol is ok – if I switched – it’s socially
acceptable. But methadone/phy – "oh, the
guy’s on drugs". I class them as ignorant
people. I do it for myself. I don’t take the
stigma on board.’
Stuart: There’s definitely a stigma though. You’re
in the chemist, taking it there and there’s
oul wans there with prescriptions and they
look down on you. It does bother me. You
get a certain look. People’d be whispering
and looking.’
Denise: ‘There’s a stigma. I overhear people talk. It
makes me feel like shit when I stand there
listening. People don’t know I’m on it. I try
to hide it.’
These accounts highlight the intersubjectivity of
respect: it arises in the course of interactions
between two or more persons. Derek, Stuart and
Denise all experience a lack of respect from other
persons, which affects their self-respect, which in
turn influences their responses to the other persons
(ignorant people, oul’ wans) and their behaviours,
such as Denise concealing the fact that she is on
methadone treatment. 
The contributors to Hyper deserve congratulations
for their courage in revealing their experiences of
respect and self-respect so openly and frankly.
They provide insights into a critical aspect of their
relationships with other people. But it is only part
of the story. If other actors in the area of illegal
drugs – policy makers, researchers, the media,
treatment professionals, law enforcers – were to
give their side of the story, with equal candour,
valuable insights into the individuals’ sense of
identity and power, as well as the functioning of
equality in such situations, would be obtained.
(Brigid Pike) 
1. The complete series of Hyper is available in hard copy in
the National Documentation Centre on Drug Use.
2. In 2004 Brigid Pike completed an MSocSc dissertation
‘Respect and self-respect in everyday life: A survey of
theoretical and methodological approaches with special
reference to illegal drug users as an example of a socially-
excluded group’. The dissertation is available online in the
National Documentation Centre.
3. See National Economic and Social Forum (2002) A strategic
policy framework for equality issues. Dublin: National
Economic and Social Forum.
4. The experiences of respect described by drug users
undergoing treatment or rehabilitation differ from those
described in relation to other users at different stages of their
drug-using ‘career’. Cf.  P Bourgois (2003) In search of
respect: crack dealers in Barrio. 2nd edition. Cambridge
University Press; T Williams (1990) The cocaine kids. London:
Bloomsbury Publishing; B Hanson et al. (1985) Life with
heroin. Lexington MA: Lexington Books. Notwithstanding the
differences, each perspective reveals a common set of
principles governing the functioning of respect.
5. H S Becker (1963) Outsiders. New York: The Free Press.
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On 25 April 2005 the Minister of State at the
Department of Health and Children, Mr Sean
Power TD, announced the publication of The
Health of Irish Students report.1 The report
incorporates the results of the College Lifestyle and
Attitudinal National (CLAN) survey and a
qualitative evaluation of the College Alcohol Policy
Initiative. The aim of the CLAN survey was to
establish a national student profile of lifestyle
habits, including living conditions, general health,
mental health, dietary habits, exercise habits,
accidents and injuries, sexual health and substance
use – tobacco, alcohol and illicit drugs. This
information will be used in planning for student
needs and as a baseline in monitoring trends over
time. This article will focus on the CLAN survey
and its results in relation to student alcohol and
illicit drug use.2
With regard to alcohol use, three out of every four
drinking occasions were binge drinking occasions
for male students, compared to three out of every
five for female students. Binge drinking is a term
used to describe a single occasion of excessive or
high-risk drinking, defined in this survey as
drinking at least four pints of beer or a bottle of
wine or equivalent at one drinking occasion. These
figures indicate that this pattern of high-risk
drinking is the norm among college students, with
more male than female binge drinkers.
The likelihood of students experiencing adverse
consequences from their own drinking increased
with more frequent binge drinking episodes.
Students who were regular binge drinkers, defined
as binge drinking at least weekly, were three times
more likely to have experienced money problems
(32% vs. 10%), fights (22% vs. 6%), accidents
(13% vs. 4%) and unprotected sex (19% vs. 6%)
than were students who were binge drinking less
frequently, or were not binge drinkers. Regular
binge drinkers were also twice as likely as other
student drinkers to be current smokers (38% vs.
18%) and recent cannabis users (54% vs. 25%).
Regular binge drinking can also interfere with
academic performance. For example, regular binge
drinkers were twice as likely to miss classes due to
alcohol (61% vs. 27%) and to report that their
studies were affected (39% vs. 19%).  
With regard to drug use, cannabis was the most
common illicit drug used by students, with over
one-third (37%) reporting that they had used it in
the past 12 months (Table 1). Ecstasy was the
second most used illicit drug, followed by cocaine,
magic mushrooms and amphetamines. For all
drugs, the levels of use were higher among
students than among those of a similar age group
(15–24 years) in the general population (Table 1).
The use of solvents (inhalants) was particularly
high. Male students were more likely to use illicit
drugs than were female students. Significant
differences (p<0.01) between genders were
observed for cannabis, ecstasy, cocaine, magic
mushrooms and solvents.
The report recommends ten actions required to
ensure that the college environment is more
conducive to the positive health and well-being of
all students. Acknowledging that alcohol-related
harm was particularly high and of major concern,
the report recommends the implementation of all
five elements of the college alcohol policy
framework.3 In addition, the report recommends
that a programme of ongoing research should be
agreed to allow for monitoring of trends and
evaluation of programmes and interventions. 
The CLAN survey was carried out among
undergraduate full-time students in 21 third-level
colleges in Ireland during the academic year
2002/2003. The colleges included seven
universities, twelve institutes of technology and
two colleges of education. A national sample size
was calculated using a three per cent precision and
a 95 per cent degree of confidence, with a
CLAN survey reveals high levels of alcohol
and drug use among college students
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Table 1   Illicit drug use in past 12 months by undergraduate full-time students (CLAN survey) compared
to those aged 15–24 years in the general population
Used in last 12 months CLAN survey General population*
(15–24 years)
% %
Cannabis 37.3 11.0
Ecstasy 8.0 2.8
Cocaine 5.8 2.7
Magic mushrooms 4.9 1.1
Amphetamines 4.5 1.2
Solvents 2.2 0.2
LSD 1.7 0.2
Heroin 0.4 0.2
* National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005) Drug use in Ireland &
Northern Ireland. Bulletin 1. First results (revised) from the 2002/2003 drug prevalence survey. Dublin: National Advisory
Committee on Drugs.
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breakdown for the colleges based on each college
population. Each participating college generated a
random sample from its computerised enrolment
list of full-time undergraduate students, distributed
the self-completed survey questionnaire by mail to
selected students and collected the completed
questionnaires by mail or by using drop-off points
on campus. 
A total of 3,259 students responded to the survey,
giving a reported response rate of 50 per cent. No
information is given in the report about those who
did not respond, so it is not possible to tell if they
differed in any way from those who did respond.
Of those who did respond, 38 per cent were male
and 62 per cent were female. Based on
Department of Education and Science figures, the
gender breakdown for persons receiving full-time
education in the academic year 2002/2003 was 46
per cent male and 54 per cent female.4 Thus there
would appear to be a slight over-representation of
female students in the CLAN survey. (Hamish
Sinclair)
1. Health Promotion Unit (2005) The health of Irish students.
Dublin: Health Promotion Unit, Department of Health and
Children.
2. Hope A, Dring C and Dring J (2005) College Lifestyle and
Attitudinal National (CLAN) Survey. In: Health Promotion
Unit. The health of Irish students. Dublin: Health Promotion
Unit, Department of Health and Children.
3. Health Promotion Unit (2001) Framework for developing a
college alcohol policy. Dublin: Health Promotion Unit,
Department of Health and Children.
4. Department of Education and Science (2004) Statistical
Report 2002/2003. Dublin: Stationery Office.
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The HSE and the National Drugs Strategy
On 1 January 2005 the Health Service Executive
(HSE) was established to manage Ireland’s public
health sector as a single national entity.1 It replaced
the former health boards, which had responsibility
for 23 actions in the National Drugs Strategy, and
joint responsibility for a further 11 actions.
Responsibility for these actions has transferred
across to the HSE. The new governance
arrangements, whereby the chief executive officer
of the HSE is now directly accountable to the
Oireachtas for the performance and management
of the HSE, may be expected to have an impact on
drugs policy co-ordination and implementation. 
The National Drugs Strategy outlines a three-tiered
co-ordination structure, including the Cabinet
Committee on Social Inclusion, comprising
government ministers; the Inter-Departmental Group
(IDG), comprising representatives from government
departments, including the Department of Health
and Children; and the National Drugs Strategy Team
(NDST), chaired by an official from the Department
of Health and Children and comprising
representatives of departments, state agencies and
the voluntary and community sectors. 
The Mid-Term Review of the National Drugs
Strategy addresses the question of where the HSE
fits in to this co-ordination structure. It
recommends that the IDG be expanded to include
senior-level representation not only from
government departments but also from the HSE
(and other state agencies, including the National
Advisory Committee on Drugs, the National
Assessment Committee of the Young Persons’
Facilities and Services Fund and the Irish Prison
Service), and from the voluntary and community
sectors. The Mid-Term Review also recommends
that both the Department of Health and Children
and the HSE be represented on the NDST, but
notes that the Department of Health and Children
believes that it no longer has a role on the NDST.
Published in March 2005, the HSE’s National
Service Plan (NSP) for 2005 outlines how the HSE
intends to deliver its drug treatment services.  The
management of all addiction services will be under
the remit of the Social Inclusion Services, but the
management of methadone treatment services also
appears under the remit of Primary Care Services
and the management of detoxification also
appears under the remit of Mental Health Services.
Therefore, it is unclear who is responsible for which
aspects of the addiction services at present.  The
NSP emphasises that responses to the needs of
those dependent on drugs or alcohol require a
partnership approach across organisational
boundaries, including drug task forces, together
with clear strategies to prevent and reduce levels
of drug or alcohol misuse and harm. The plan also
endorses a needs-based approach to the delivery
of services that minimises disadvantage. 
A clear alignment with the National Drugs Strategy
is established through the commitment made in
the NSP to Action 22 of the national health
strategy, Quality and Fairness, which states that all
relevant actions in the National Drugs Strategy will
be implemented by 2008.  Moreover, the NSP
commits Addiction Services, within Social Inclusion
Services, to providing six-monthly reports to the
Department of Community Rural and Gaeltacht
Affairs on the implementation of the National
Drugs Strategy, supporting the Health Research
Board (specifically the National Drug Treatment
Reporting System), and implementing the work
programme (i.e. report recommendations) of the
National Advisory Committee on Drugs. 
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The NSP states that the HSE’s Addiction Services
will monitor the two key performance indicators in
the National Drugs Strategy that relate to
timeliness of access to treatment services and
access to treatment for under-18-year-olds.
Specifically, these are: 
■ Immediate access (within 3 days) to
professional assessment and counselling by
health board services and the
commencement of treatment not later than
one month following assessment.  One
month is defined as 28 days.  
■ Development of age-appropriate guidelines
on problem drug users aged less than 18
years and access to treatment (Jean Long,
personal communication, 2005)
The NSP states that Addiction Services will also
ensure the finalisation of the service users’ charter
for drug initiatives.  
In June of this year the HSE is due to publish its
first corporate plan, which will set out the HSE’s
goals and strategies for the next three years. This
plan may be expected to reveal more information
about how the HSE will seek to implement
recommendations in the Mid-Term Review of the
National Drugs Strategy relating to: 
■ an audit of the current availability of
treatment options, including an assessment of
treatment needs and methods of tracking
ongoing developments, to be completed by
mid-2006;
■ increasing the availability and range of drug-
related treatment options, including
detoxification;
■ expanding the provision of needle-exchange
and harm-reduction services to ensure wider
geographic availability and availability at
evenings and weekends;
■ increasing the numbers of GPs and
pharmacies participating in the methadone
protocol. (Brigid Pike)
1. The Health Service Executive was established as a statutory
body by the Health Act 2004. 
The HSE and the National Drugs Strategy (continued)
Heroin misuse in Athlone and Portlaoise 
The Midlands Regional Task Force commissioned
Niall McElwee and Grainne Monaghan to examine
heroin misuse in Athlone and Portlaoise.1 Athlone is
on the main route from Dublin to Galway;
Portlaoise is situated on the main Dublin to
Cork/Limerick road. The researchers employed a
‘relational child and youth care model’ to uncover
and present the views and experiences of heroin
users and service providers in the two towns.  They
collected the data through interviews with heroin
users and service providers. Their findings were
triangulated using quantitative and qualitative
information from a variety of stakeholders.  
According to the authors’ findings:
■ In the urban area of Athlone in 1996, two-
fifths of the population had no second-level
qualifications.  In February 2000, 1,391
persons were unemployed.  At the time of
the study, one local authority housing estate
in west Athlone had an identifiable substance-
use problem. The authors noted the difficulty
in quantifying the numbers using heroin
because figures varied between sources. In
2004, the local media reported that there
were approximately 100 heroin users living in
the town and, at the same time, service
providers estimated that there were between
60 and 500 users.  In 2003, 39 cases were
receiving treatment for problem opiate
misuse through the Athlone Addiction
Counselling Services.  Service providers
believed that poverty and disadvantage were
strongly linked to heroin use in the town.
Many service providers reported that the
location of a treatment centre in Athlone,
with a transient clientele from Dublin, had
contributed considerably to heroin use. There
was an increase in heroin use among women
in Athlone, with many of them introduced to
heroin use by their partners.  One focus
group reported that the majority of their
clients started smoking heroin but then
progressed to injecting.  According to the
service providers, a large proportion of their
clients were hepatitis C positive. The service
providers stated that their clients’ heroin
habits were funded through criminal activity
and prostitution (both male and female).
Users spent anything from €50 to €1,000
per week to feed their habits. 
■ The population living in the urban area of
Portlaoise was 3,842 in 2002.  In 2002, 19
per cent of the urban population had not
completed primary level education and 20
per cent of those aged over 15 years were
unemployed.  There are a number of high-
density local authority housing estates in
urban Portlaoise.  In 2002, Garda sources
reported that there were approximately 50
persons using heroin in Portlaoise. According
to the service providers, the figures varied
from 70 to 250 persons misusing heroin. In
2003, 30 cases received treatment for
problem opiate use from the Portlaoise
Addiction Counselling Services. The service
providers reported that most of the heroin
was brought down from Dublin.  The
treatment providers in the town stated that
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50 per cent of their clients were female and
that very few heroin users injected. It was
found that criminal activity to fund heroin
was a recent phenomenon and, to date,
prostitution was not a serious problem in
Portlaoise. There was only one pharmacy
dispensing methadone in Portlaoise at the
time of the study and the lack of such
pharmacies was seen as a critical issue. 
Following focus groups and pilot interviews, a
refined questionnaire was developed and data
were collected between October and November
2004. In the two towns, the study participants
were selected using personal contact, key
informants, media appeals or a snowballing
technique.  Of the 143 questionnaires distributed,
only 16 (11%) were returned to the researchers.
According to the authors, the response rate was
much lower than expected and many potential
respondents failed to keep appointments for
interviews.  
The key survey findings were:
■ Over half (8/15) of respondents were female.
■ Ten of the 16 respondents were under 30
years old.
■ Twelve of the 15 respondents lived in
Athlone, while only two lived in Portlaoise.
■ Only one of the 16 respondents was brought
up in Dublin.
■ Seven of the fourteen respondents left school
before their sixteenth birthday.
■ Four of the 16 respondents were currently
employed.
■ Of the 16 respondents, nine drank alcohol;
seven drank for two or more successive days.
■ Of the respondents who answered the
question, six were currently using heroin, five
were currently using other drugs, 15 had ever
used cannabis, 14 had used heroin and 10
had used cocaine.  
■ Just over half of the respondents had used
heroin by their 18th birthday;
■ Of the 16 respondents, six injected heroin;
■ The main reasons for taking heroin were to
boost feelings of well-being and to overcome
problems; 
■ Of the 16 respondents, nine said that they
received treatment.  
The majority of problem heroin use is concentrated
in specific local authority areas.  According to the
authors, the Midland’s addiction service requires a
client-centred approach to treatment, needle
exchange outlets, an inpatient detoxification unit,
stabilisation facilities and rehabilitation
interventions.  There is a need for a dedicated
addiction service response for those aged under18
who are misusing drugs. (Jean Long and Fionnola
Kelly)
1. McElwee N and Monaghan G (2005) Darkness on the edge
of town: an exploratory study of heroin misuse in Athlone and
Portlaoise. Athlone Institute of Technology and Midlands
Regional Drugs Task Force. 
Heroin misuse in Athlone and Portlaoise (continued)
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Understanding substances and substance
use: A handbook for teachers
On 15 December 2004 the Substance Misuse
Prevention (Walk Tall) Programme of the Department
of Education and Science hosted the launch of
Understanding substances and substance use: A
handbook for teachers by Minister Mary Hanafin TD.
The handbook is intended as a resource for teachers
delivering substance use education in the context of
Social Personal and Health Education (SPHE) in both
primary and post-primary schools.1 It was developed
and produced by the Walk Tall Programme in
partnership with the Addiction Services and Health
Promotion Department of the South Western Area
Health Board.
The handbook includes material on defining
substance terminology; theoretical stages of
substance use and risk and protective factors
surrounding substance use. In addition there is
information on how substances can be ingested,
their effects and their legal status. There is also
material on developing drug education and drug
policies in schools. 
Section five of the handbook includes key insights
into the Zinberg approach to understanding
substance use, while section eight addresses the
recent phenomenon of home drug testing. Both
sections are treated to a more discursive approach
below in an attempt to draw out some of the key
points. 
Section five highlights the 'epidemiological triangle
of drug use' that describes the three factors that
impact on all stages of drug use. This section is
grounded in the theoretical proposition of Zinberg.2
According to Zinberg there are three key factors in
play when drugs are being used; the make up and
compound of the drug itself (drug), the psychology
of the person taking the drug (set) and the social
environment in which the drug is taken (setting).
Reference to the framework provides for the
removal of the temptation to demonise the
properties of drugs as solitary effect producers,
without considering the psychological condition
and social context of the user. Such demonisation is
not dissimilar to the 'scare tactics' approach to drug
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education that Morgan (2001) cautions against.3
Both approaches are based on the premise that
when ingested, often on the first occasion, the
properties of certain drugs will result in irreversible
experiences such as addiction or criminality.
Overstating the probability of such experiences can
result in the loss of credibility between students and
teachers, particularly if students have experience of
their peers using drugs without evidence of major
consequences. The drug, set and setting framework
can be useful for teachers in classroom discussion,
particularly in secondary school drug education, as
it allows teachers to address the issues without
denying or demonising the effects that drugs can
produce, but by understanding such effects
through the interaction between us, the drug and
our environment. 
Section eight addresses the signs and symptoms of
drug use and the issue of home drug testing. The
section highlights the need for teachers and
parents to be aware that signs and symptoms that
may traditionally be linked to drug use, such as
erratic mood swings, changes in appearance and
loss of interest in school, are also normative
aspects of the experience of adolescence. The
inclusion of the issue of home drug testing is a
welcome contribution to the debate on the merits
or otherwise of using such tests. The section
highlights a number of practical, ethical and legal
issues that require consideration from schools or
parents prior to the use of this form of drug
testing, for example:
■ How will the test impact on the relationship
between the young person and their parents
or school in terms of trust?
■ How will a urine sample (most common way
of testing) be obtained? Any degree of
coercion has quite serious legal implications
for either the parents or the school in terms
of the young person’s rights.
■ Are the results reliable? For example, unlike
medical professionals who normally carry out
such tests, schools and parents are unlikely to
be appropriately trained to obtain the
sample, carry out the test and interpret the
results.  In addition, false positives can result
if the individual has been taking over-the-
counter medicines containing codeine or
opiate derivatives. 
The handbook is a welcome contribution to the
task of 'educating the educators' on drug-related
information and can play a useful role in assisting
schools to deliver quality drug education and
develop and implement a drug policy as
recommended in the National Drugs Strategy.
(Martin Keane)
1. Keane R, Reaper-Reynolds S, Williams J and Wolfe E (2004)
(Eds) Understanding substances and substance use: a
handbook for teachers. Dublin: Addiction Services and
Health Promotion Department, South Western Area Health
Board and the Substance Misuse Prevention Programme,
Department of the Education and Science.
2. Zinberg NE (1984) Drug, set, and setting: the basis for
controlled intoxicant use. New Haven: Yale University Press.
3. Morgan M (2001) Drug use prevention: overview of research.
Dublin: National Advisory Committee on Drugs.
To obtain copies of the handbook, contact Mary
Johnson, National Co-ordinator of Walk Tall at 087
2839218. A copy is also available in the National
Documentation Centre on Drug Use.
Understanding substances and substance use (continued)
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Prevalence of alcohol and drug use among
the homeless population in Ireland
Lawless and Corr1 at Merchants Quay Ireland
assessed the nature, extent and experience of
alcohol and drug use among people who were
homeless in four cities in Ireland, namely: Cork,
Dublin, Galway and Limerick.  The report was
prepared for the National Advisory Committee on
Drugs and launched in April 2005.  Homelessness
was defined as living in a hostel or shelter, a bed
and breakfast, or a squat, or living temporarily with
family or relatives.  In Cork, Galway and Limerick,
the definition was extended to include transitional
housing or long-term supported housing.  
In Dublin, the sample was selected using a quota
sampling based on gender, age and primary
accommodation type, while in Cork, Galway and
Limerick the quota sample was based on primary
accommodation.  The majority (247, 70%) of the
sample was recruited in Dublin and the remainder
(108, 30%) in the other three cities.  The 355
participants were recruited from among those in
contact with homeless services in the four cities.
Drug treatment centres and needle exchange
facilities were excluded from the list of services so as
to avoid over-estimating the prevalence of drug use. 
Between June and October 2003, nine field
workers interviewed the participants using a semi-
structured questionnaire, which:  
■ Elicited information regarding basic identifiers,
personal characteristics, accommodation
types, experiences of homelessness, income,
health, alcohol and drug use, risk behaviours,
contact with services and current needs;  
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■ Measured problem alcohol use using a
validated tool known as the Alcohol Use
Disorders Identification Test Screening
Instrument (AUDIT);  
■ Assessed drug use through three approaches,
which included:
- European Monitoring Committees Drug and
Drug Addiction (EMCDDA) standard
questions on lifetime, recent and current
use of various drug classifications;
- A 10-point version of the Drug Abuse
Screening Test to identify problematic drug
use;
- Severity of Dependence Scale to measure
the degree of dependence on a variety of
drugs.
Each person interviewed was allocated a unique
identifier (initials, gender and date of birth) and
these identifiers were shared between the
fieldworkers so as to avoid respondents
participating more than once.  
This article presents the prevalence of alcohol and
drug use among the homeless.  The main findings
are as follows:
■ Of the 355 participants: 
• 101 (28%) were less than 24 years old,
while 161 (35%) were more than 34 years
old; 
• 244 (69%) were male.
■ Of the 352 participants for whom location
and type of accommodation were known:
• Half (176) were living in a hostel, just
under one-fifth (69) were staying in bed
and breakfast accommodation, 56 (16%)
were sleeping rough and the remaining 15
were staying in other accommodation; 
• 245 (70%) lived in Dublin while 36 (10%)
lived in each of the other cities, Cork,
Galway and Limerick;
■ Of note, 19 per cent of respondents reported
that drug use was the main reason for their
becoming homeless, while 13 per cent
reported that alcohol was the main reason;  
■ Of the 352 for whom frequency of alcohol
use was known, 105 (30%) were not drinking
alcohol at the time of the survey, while 83
(23%) consumed alcohol on four or more
days per week;
■ 247 participants reported alcohol use at the
time of the survey and were screened for
problem alcohol use, 73 per cent had an
alcohol problem and 49 per cent of these had
a high-level alcohol problem.
■ Of the 355 participants, 
• 74 per cent reported illicit drug use at
some point in their life, 64 per cent
reported illicit drug use in the year
preceding the study and 52 per cent had
reported illicit drug use in the month
preceding the study (Table 1);  
- Gender was not associated with current
drug use;
-  A lower proportion of hostel dwellers
(43%) reported current drug use than did
those sleeping rough (73%) or staying in
bed and breakfast accommodation (67%); 
-  A higher proportion of homeless living in
Dublin were current drug users than the
proportions living in each of the other
cities;
• Cannabis was the most common illicit drug
used, with 69 per cent using it at some
point in their life, followed by heroin
(42%), ecstasy (42%), cocaine powder
(41%), amphetamines (35%),
hallucinogens (28%), crack cocaine (19%)
and solvents (16%);
• Cannabis was the most common (43%)
illicit drug used in the last month, followed
by heroin (22%), cocaine powder (17%),
ecstasy (12%), crack cocaine (3%)
amphetamines (2%), hallucinogens (1%),
and solvents (1%);
• 45 per cent were using more than one
drug at the time of the study and this
represents 72 per cent of current drug
users;
■ Using the DAST screening instrument, 36 per
cent of the 355 participants were classified as
problem drug users and 65 per cent of the
183 current drug users were problem drug
users;
■ Using the Severity of Dependence Scale, 43
per cent of the scores of the 183 current drug
users indicated a high level of psychological
dependence. 
Alcohol and drug use among the homeless population (continued)
Of the 355
participants, 74
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Table 1   Prevalence of illicit drug* use in the homeless population in Ireland in 2003
Total (355) Dublin (245) Cork (36) Limerick (36) Galway (36)
Per cent
Lifetime use 74 80 72 42 64
Recent use 64 72 53 28 50
Current use 52 59 42 25 36
*Illicit drugs are cannabis, ecstasy, amphetamines, cocaine powder, crack cocaine, heroin, hallucinogens and solvents.
Of note, 
19 per cent of
respondents
reported that drug
use was the main
reason for their
becoming
homeless, while 13
per cent reported
that alcohol was
the main reason.
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As expected, drug use is much more common
among the homeless population than among the
general population.1,2 The profile of drug use
reported by the homeless population in 2003 is
similar to that reported by the prison population in
1999,3 indicating the high-risk substance use
among these two populations and, possibly,
considerable overlap between the prison and the
homeless population. (Jean Long)
1. Lawless M and Corr C (2005) Drug use among the homeless
in Ireland. Dublin: Stationery Office.  
2. National Adivsory Committee on Drugs and Drug and
Alcohol Information and Research Unit (2003) Drug use in
Ireland and Northern Ireland. Bulletin 1. First results from the
2002/2003 drug prevalence study. Dublin: National Advisory
Committee on Drugs. 
3. Centre for Health Promotion Studies, National University of
Ireland, Galway (2000) General health care study of the Irish
prison population. Dublin: Stationery Office.
Alcohol and drug use among the homeless population (continued)
Prison needle exchange
Lessons from a comprehensive review of
international evidence and experience 
On 18 November 2004, Merchants Quay Ireland
and the Penal Reform Trust launched a report that
examined the issue of prison needle exchange
based upon the international experience up to 31
March 2004.1
The authors completed a literature review, visited
prisons in four countries, and corresponded with
people responsible for administering prison needle
exchange programmes. The report provides a
comprehensive review of the evidentiary and legal
basis for prison needle exchange programmes. 
The need for an effective response to the issues of
HIV, hepatitis C, and injection drug use in prisons
is a significant international concern. In many
countries, including Ireland, rates of HIV and
hepatitis C infection in prison populations are
much higher than those in the general population.
In many countries, the epidemics of HIV and
hepatitis C in prisons are linked to injection drug
use and to unsafe injection practices. 
Needle exchange programmes have proven to be
an effective harm-reduction measure that reduces
needle sharing, and therefore the risk of HIV and
hepatitis C transmission, among people who inject
drugs. As a result, many countries have
implemented these programmes within community
settings to enable people who inject drugs to
minimise their risk of contracting or transmitting
HIV and hepatitis C through needle sharing. 
Despite the success of these programmes in the
community, only six countries (Switzerland,
Germany, Spain, Moldova, Kyrgyzstan, and
Belarus) have extended needle exchange
programmes into prisons. Other countries,
including Kazakhstan, Tajikistan, and Ukraine may
follow in the near future.
Needle exchange programmes have been
implemented in some of these prisons since 1992,
in each case in response to significant evidence of
the risk of HIV transmission within the institutions
through the sharing of injecting equipment.
Needle exchanges in prisons were typically
implemented on a pilot basis, and later expanded
based on the experience during the pilot phase.
Several different methods of syringe distribution
are employed, including:
■ Automatic dispensing machines; 
■ Hand to-hand distribution by prison
physicians or healthcare staff or by external
community health workers; 
■ Programmes using prisoners trained as peer
outreach workers.
The experience and evidence from the six countries
where prison needle exchange programmes exist
demonstrate that such programmes: 
■ Do not endanger staff or prisoner safety and,
in fact, make prisons safer places to live and
work;
■ Do not increase drug consumption or injecting;
■ Reduce risk behaviour and disease (including
HIV and hepatitis C) transmission;
■ Have other positive outcomes for the health
of prisoners;
■ Have been effective in a wide range of prisons;
■ Have successfully employed different methods
of needle distribution to meet the needs of
staff and prisoners in a range of prisons.
According to Rick Lines, one of the authors, the
goal of this report is to encourage prison systems
with HIV and hepatitis C epidemics driven by
injection drug use to implement needle exchange
programmes.  He cautions that the failure to
provide prisoners with access to essential HIV and
hepatitis C prevention measures is a violation of
their right to health in international law.  At the
launch of the report, he also highlighted that
failure to continue needle exchange in prison
reduces the effectiveness of needle exchange in
the community. (Jean Long)
1. Lines R, Jurgens J, Betteridge G, Stover H, Laticevschi D,
Nelles J (2004) Prison needle exchange: lessons from a
comprehensive review of international evidence and
experience. Montréal: Canadian HIV/AIDS Legal Network.  
This report is available on the website 
of the Canadian HIV/AIDS Legal Network at
www.aidslaw.ca/Maincontent/issues/prisons.htm,
or can be ordered from the Canadian HIV/AIDS
Information Centre; Tel + 1 613 725-3434; Fax +1
613 725-1205; Email: aidssida@cpha.ca.
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Minister of State Noel Ahern TD, in a submission to the Joint
Oireachtas Committee on Justice, Equality, Defence and
Women’s Rights, outlined his intention to extend the
Community Policing Forum model, developed in a number of
Local Drugs Task Force areas, to all remaining LDTF areas and to
other areas of high drug misuse throughout the country.
The Joint Committee was conducting a review of community
policing in Ireland in light of proposals contained in chapter four
of the Garda Síochána Bill 2004 to establish new local policing
structures.
Over the last few years we have seen the development of a
number of community policing fora throughout Dublin. These
have grown largely out of community demands for improved
policing in the context of the drugs crisis in many parts of the
city. With the establishment of local drugs task forces, many of
these fora have been established on a more formalised basis. The
National Drugs Strategy 2000–2008 highlights the importance of
community policing fora to the development of local drugs task
forces. Action 11 aims ‘to extend the Community Policing Fora
initiative to all LDTF areas, if the evaluation of the pilot proves
positive.’1
In light of the positive evaluation of the north east inner city
model,2 and following submissions received during the mid-term
review of the National Drugs Strategy, Minister Ahern, who has
responsibility for the Strategy, informed the committee:
…the community policing fora currently operate in three
local drugs task force areas in Dublin – the north inner
city, Cabra, and the south inner city. While slightly
different approaches have been taken in the different
areas, the model preferred by contributors to the mid-
term review, particularly community groups, is the one
that operates in the north inner city. This model involves
the appointment of a civilian community co-ordinator
who liaises between the Garda and the local community.
There is a management committee, involving senior
officials from the Garda and Dublin City Council and
community representatives.
The Joint Committee also received submissions from
representatives of the community policing fora in Cabra,
Blanchardstown,3 the north east inner city and Rialto. 
A report from Cabra presented to the Joint Committee detailed
an intensive programme of local resident meetings and
consultations with other stakeholders, organised in preparation
for the establishment of a local community policing and estate
management forum. The report also makes a number of
recommendations to advance such a process, including:
proposed terms of reference, aims and objectives, a schedule of
meetings, and proposed membership of the forum.4
Representatives of the Rialto Community Network referred to
the Rialto Community Policing Forum, which has been
suspended due to the absence of resources.
Among the concerns raised by local drugs task forces before the
Committee were representation of the community and
voluntary sector on the proposed Joint Policing Committees and
the status of the existing policing fora. With regard to the latter,
concerns were expressed about a provision in the Bill which
necessitates the Garda Commissioner’s consent for the
establishment of local fora.5 The Minister for Justice, Michael
McDowell TD, explained the rationale behind this aspect of the
Bill:
The reason for the precondition of the Commissioner’s
consent is fora will have to be serviced. There is no point
in having an unserviced forum. I do not want a scenario
where attendance at fora becomes so onerous that when
the Commissioner has his officers out from behind their
desks, they spend their evenings debating local policing
conditions all the time. He must have control.
However, Fergus McCabe, speaking in his capacity as a member
of the Management Board of the North Inner City Community
Policing Forum, stated his opposition to the provision:
It is wrong that the Garda Síochána has a veto. In terms
of the partnership approach, one of the good things
about the north inner city has been the level of trust
which has developed. Informing and consulting the
community does not take away from the operational
autonomy of Dublin City Council and the Garda, both of
which still have statutory and legal responsibility for
whatever they do. There is absolutely no need for that
type of veto approach that is inimical to the partnership
system.
In relation to the membership of Joint Policing Committees, the
Oireachtas Committee recommended:  ‘That a transparent
procedure should be put in place to facilitate the involvement of
Community and Voluntary representatives’ and, with regard to
the local policing fora, ‘The decision to establish local fora
should be made by the Joint Policing Committee in consultation
with the relevant Chief Superintendent.’ (Johnny Connolly)
1. Department of Community, Rural and Gaeltacht Affairs (2001) National
Drugs Strategy 2001–2008. Dublin: Stationery Office.
2. Drugnet Ireland Issue 8, June 2003.
3. Drugnet Ireland Issue 13, Spring 2005. See also Connolly J (2004)
Developing integrated policing – towards the Blanchardstown Community
Policing Forum. Dublin: Blanchardstown Drugs Task Force.
4. Cabra Community Policing Forum (2004) Report 2003–2004. Dublin:
Finglas/Cabra Local Drugs Task Force.
5. As per s32 (2) (d), the Joint Policing Committee can ‘with the Garda
Commissioner’s consent, establish, as the committee considers necessary
within specific neighbourhoods of the area, local policing fora to discuss
and make recommendations to the committee concerning the matters
referred to in paragraph (a) as they affect their neighbourhoods.’
The report and recommendations of the Joint 
Committee are available on the Oireachtas website at
www.oireachtas.ie 
Minister addresses Joint Oireachtas Committee on
Community Policing
13
drugnet
IRELAND
Arrest referral in the north inner city
The main aim of arrest referral schemes is to
provide information to arrestees about appropriate
services and to facilitate referral to treatment at the
primary points of entry into the criminal justice
system, usually the police station. Arrest referral is
an early intervention aimed at people who have
been arrested and whose offence may be linked to
drug use. Such policies are premised on the idea
that treatment will lead to a reduction or cessation
of illicit drug use and will thus reduce or negate
further drug-related offending by the drug user.
UK research suggest that for every Stg£1 spent on
treatment, Stg£3 is saved on the cost of law
enforcement.   
Juvenile arrest referral schemes are consistent with
the principles outlined in the Children Act, 2001,
which emphasises prevention and the diversion of
young offenders from prosecution. Action 13 of
the National Drugs Strategy 2001–2008 obliges An
Garda Síochána ‘To monitor the efficacy of the
existing arrest referral schemes and expand them,
as appropriate’. Action 19 promotes such early
intervention approaches to problem drug use:
‘Incidences of early use of alcohol or drugs by
young people coming to Garda attention to be
followed up by the Community Police and/or the
health and social services, in order that problem
drug misuse may be diagnosed/halted early on
through appropriate early intervention’.1
A summary report published by the North Inner
City Drugs Task Force and funded by the
Department of Justice, Equality and Law Reform on
a pilot arrest referral scheme in Dublin’s north
inner city was launched in April by Noel Ahern TD,
Minister of State with responsibility for the
National Drugs Strategy.2
The report considers best practice approaches in
the UK, where significant progress has been
achieved in introducing arrest referral schemes. As
part of the UK’s Drugs Intervention Programme,
Stg£20million has been made available to fund
arrest referral programmes. All police forces in
England and Wales operate proactive arrest referral
schemes. The report also considers an arrest
referral scheme in operation at Gransha Hospital in
Derry, the Derry Arrest Referral Team (DART)
Alcohol/Drugs Service, and outlines three different
arrest referral intervention models. The information-
giving model provides information such as leaflets
on treatment, but there is no advice, counselling
or follow-up; the incentive or coercive model
involves cautioning an arrestee to seek advice from
a drugs worker or postponing a cautioning
decision pending attendance by the arrestee at a
drug service; and the proactive model involves
specialist arrest referral workers based in the police
stations or on call. These workers proactively
contact and assess drug-using arrestees and refer
them to treatment as appropriate. Approximately
400 arrest referral workers are employed through
these schemes in the UK.
The north inner city pilot scheme involves co-
operation between the outreach services of the
Health Service Executive Northern Area, An Garda
Síochána North Central Division and the local
drugs task force. Participation in the scheme is
completely voluntary for arrestees and does not
interfere with the normal processing of the
criminal justice system. The initial take-up of the
scheme has been low. The report provides data for
juveniles arrested in the North Central Division
stations of Store Street, Mountjoy, Bridewell and
Fitzgibbon Street between May and September
2003. Of the 214 arrestees, 167 were male. Only
14 (6.5%) of these arrests were made under the
Misuse of Drugs Act (MDA) 1977. 
The take-up rate for the scheme is reported as
‘quite low’ with only a small number of individuals
referred to the health services. The report
acknowledges that many young arrestees will not
see their drug use as problematic but rather as
‘dabbling’ or ‘recreational’ and will therefore not
seek help. Also, the low number of MDA-related
arrests leads the authors to question whether the
scheme should be broadened to all juvenile
arrestees, ‘regardless of their offence within
appropriate qualifications’.2
Arrest referral is
an early
intervention
aimed at people
who have been
arrested and
whose offence
may be linked to
drug use.
From left: Mel MacGiobúin (North Inner City
Drugs Task Force Coordinator), Michael
Feehan (Chief Superintendent, Dublin North
Central Division), Noel Ahern TD (Minister of
State with responsibility for National Drugs
Strategy), Al McHugh (Assistant
Commissioner, Dublin Metropolitan Region).
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The low take-up rate of the scheme is consistent
with data provided by the National Drug Treatment
Reporting System. Table 1 shows the number and
percentage of cases reported to the National Drug
Treatment Reporting System by court, probation or
police.  As can be seen, the proportion of cases
referred from these criminal justice agencies is low
and has remained relatively unchanged between
1998 and 2002. The low take-up rate in the Dublin
scheme is consistent with findings from other such
schemes in their early stages. Referrals in the Derry
scheme increased from 85 in 2001 to 249 in 2003.
Similarly, as the pilot becomes increasingly
established in the north inner city, the gardaí report
that the number of referrals is also growing.
The primary recommendation of the report is that
the pilot phase of the scheme should be extended,
with additional resources in terms of staff,
programme development and monitoring. 
(Johnny Connolly)
1. Department of Tourism, Sport and Recreation (2001)
Building on experience: National Drugs Strategy 2001–2008.
Dublin: Stationery Office.
2. North Inner City Drugs Task Force (2005) Changing track: a
study informing a juvenile arrest referral pilot in the North
Inner City. Dublin: North Inner City Drugs Task Force.
Copies of the summary report can be obtained
from the North Inner City Drugs Task Force at
nicdtf@iol.ie or from the National Documentation
Centre on Drug Use at www.hrb.ie/ndc 
Arrest referral in the north inner city (continued)
Community groups carry out research on
local drug issues
In the last issue of Drugnet Ireland we covered two
of the four published reports from the
Community/Voluntary Sector Research Grant
Scheme operated by the National Advisory
Committee on Drugs. This grant supported
research aimed to:
■ promote a better understanding of drug-
related issues in communities
■ boost the research capacity of the
community/voluntary sector and
consequently, their capacity to influence
policy and the planning of services
■ facilitate liaison between
community/voluntary organisations, service
planners and service providers to optimise the
development of needs based policies and
services
In this issue we cover the remaining two reports,
namely
■ Ballymun Youth Action Project:
Benzodiazepines – whose little helper? The
role of benzodiazepines in the development
of substance misuse problems in Ballymun
■ Merchants Quay Ireland: Drug use among
new communities in Ireland. An exploratory
study
Benzodiazepines – whose little helper? 
The Ballymun Youth Action Project explored the
use and misuse of benzodiazepines in Ballymun
between 2003 and 2004 using a combination of
qualitative and quantitative techniques.1
The study employed three methods: 
■ Focus groups
■ Interviews with key informants 
■ Retrospective survey of dispensing practices.  
A combination of community workers and the
research team moderated and analysed the
findings of a number of focus groups comprising:
■ Adults prescribed benzodiazepines;  
■ Problem drug users who may or may not use
benzodiazepines;
■ Treated problem drug users who no longer
used benzodiazepines;
■ Young drug users who may or may not use
benzodiazepines;
■ Members of the community and voluntary
organisations that address the consequences
of benzodiazepine use.
Table 1   The number (%) of cases reported to the National Drug Treatment Reporting System who were
referred by police, probation or court
1998 1999 2000 2001 2002
Police, probation, court 518 (8.8) 427 (7.1) 439 (6.5) 480 (6.4) 598 (7.4)
Total cases1 5862 5993 6754 7532 8116
1 Cases in which the referral source was recorded.
Source: Unpublished data from the National Drug Treatment Reporting System, Health Research Board
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The main findings from the focus groups and two
key interviews were:
■ The majority of participants first observed
benzodiazepine use in their homes.
■ Benzodiazepine use occurs among all age
groups, from the young to the elderly.
■ More women than men use benzodiazepines.
■ Reasons for therapeutic use of benzodiazepines
were: to treat anxiety and depression, to help
sleep, and to assist people to cope with a
variety of situations, including bereavement. 
■ The reasons for non-therapeutic use were: to
get a desired chemical effect, to enhance the
effect of some drugs (such as heroin) and to
reduce the effects of stimulants (such as
ecstasy and cocaine).
■ Benzodiazepines were commonly used in
combination with other drugs.
■ Prescribing practices of doctors contribute to
the problem as many people had been
receiving scripts for years.
■ Large supplies of illicit benzodiazepines were
available for purchase in the area, of which
the majority were acquired from repeat
prescriptions.
■ Another source of benzodiazepines was
bartering or sharing between residents.
■ Benzodiazepine prescribing was linked to
methadone maintenance treatment. 
■ The process of benzodiazepine detoxification
was difficult and its success rate was very low.  
■ There was a lack of factual information about
the long-term effects of benzodiazepines.
■ The problems associated with benzodiazepine
use were dependence, impaired mental
functioning, negative effects when consumed
with alcohol and extreme actions that were
opposite to the desired effect.
The following are the findings from a retrospective
survey of dispensing patterns in a limited number
of community pharmacies in Ballymun over four
separate one-week periods between December
2000 and July 2002:  
■ There were 751 instances of tablet dispensing
included in the study.
■ Almost 90 per cent of the prescriptions were
issued under the General Medical Services
scheme.
■ Over 40 doctors prescribed benzodiazepines
during the study period, but 77 per cent of
the prescriptions were written by four doctors.
■ Just under 63 per cent of the prescriptions
examined were for diazepam and almost 23
per cent were for flurazepam.
■ Almost 66 per cent of the prescriptions were
dispensed to women.
■ The type of benzodiazepine prescribed was
associated with gender.  A higher proportion
of men received flurazepam than women,
while the opposite was the case with
temazepam.  
■ Almost two-fifths of the population were first
dispensed benzodiazepines over five years ago. 
A key informant interviewed a number of medical
practitioners (either face-to-face or by phone) to
explore medical perspectives of benzodiazepines
and the findings reveal that:
■ Addressing benzodiazepine misuse must be
considered in the context of the social and
economic environment and a medical
approach on its own will not address the
problem.
■ There are different medical approaches to
managing benzodiazepine use.  These are:
abstinence, a short-term prescription followed
by detoxification and long-term maintenance. 
■ The review of repeat prescribing is hampered
by the immediate requirements of the local
population, the potential workload, and the
possible dangers associated with detoxification.
■ In instances of shared care between two
medical practitioners, clients may conceal the
fact that they have received benzodiazepine
prescriptions from the other practitioner.
■ Clients may present alcohol dependence as
anxiety or depression to the medical
practitioner so as to obtain a benzodiazepine
prescription.  
In conclusion, the authors recommend that the
root social and economic causes must be
addressed.  The management of benzodiazepine
dependence requires a multi-faceted approach
including psychological and social services rather
than an approach directed by doctors only.  
(Jean Long and Ena Lynn)
1. Ballymun Youth Action Project (2004) Benzodiazepines –
whose little helper? The role of benzodiazepines in the
development of substance misuse problems in Ballymun.
Dublin: National Advisory Committee on Drugs.  
Drug use among new communities in
Ireland: an exploratory study
This research was carried out by Merchants Quay
Ireland (MQI) and aimed to develop an in-depth
understanding of problematic drug use among
new communities in Ireland.1
Data collection methods
Three members from new communities (a Russian,
a Romanian and a Nigerian) were recruited and
trained in ethnographic fieldwork techniques. The
recruits then carried out 280 hours of fieldwork,
which included observing drug users in their own
social setting and recording informal discussions
with drug users and key informants in a daily diary.
Fieldwork included semi-structured in-depth
interviews with 10 individuals from new
communities who identified themselves as
Community groups carry out research (continued)
Among the study
findings: large
supplies of illicit
benzodiazepines
were available
for purchase in
the area, of
which the
majority were
acquired from
repeat
prescriptions.
16
drugnet
IRELAND
problematic drug users. Six interviewees were from
Africa, three from the former USSR and one from
Central/Eastern Europe. In addition, two focus
groups were conducted by the Merchants Quay
research unit: one with individuals working with
new communities in Ireland and one with drug
service providers. 
Patterns of drug use among new communities
Seven interviewees reported heroin and three
reported cocaine as their respective drugs of
choice. Five interviewees reported injecting heroin
but the sharing of injecting equipment was not
prevalent. There were also reports of drug injecting
taking place among individuals from Russia,
Estonia and Pakistan. It was reported that injecting
practices were uncommon among individuals from
Africa, who tended to smoke heroin. Some
members of the Somali community were reported
to be using Khat, a chewable green leaf stimulant,
while some members of the Russian community
were reported to make a special porridge called
Kasha, laced with cannabis. 
Factors influencing drug use
Interviewees and drug users encountered during
the fieldwork cited escape from their current
situation as a reason for continuing or initiating
drug use. Their current experiences included
feeling excluded, isolated and fearful of state
authorities. Some reported using drugs to escape
episodes of post-traumatic stress disorder arising
from their experiences of war and torture prior to
arriving in Ireland. Four interviewees had no
history of problematic drug use prior to arriving in
Ireland while one had ceased using drugs for 10
years and had restarted in Ireland. Younger
members of new communities were reported to
use drugs as a means of mixing with and gaining
acceptance from Irish peer groups, mainly in
recreational settings such as clubs. 
Ethnicity, drug use and social exclusion
Issues of social exclusion were particularly
prominent among the interviewees. Seven were
staying in emergency accommodation hostels; two
were staying with friends and one in private rented
accommodation. Eight interviewees were
unemployed and two in full-time employment.
Four were seeking asylum, four were
undocumented immigrants, one was documented
as a labour migrant and one had refugee status. 
Barriers to accessing drug services
The majority of interviewees (7) expressed an
interest in accessing treatment for their drug use but
highlighted a number of barriers that prevented
their engaging with services. For example: 
■ There was scant knowledge of methadone
maintenance programmes among
interviewees, and some were persuaded by
their Irish peers to treat methadone with
skepticism as it was perceived to be as
addictive as heroin. 
■ Those with knowledge of methadone
maintenance reported waiting lists and the
assessment procedure as discouraging barriers.
■ Many associated treatment with abstinence
and were unaware of harm reduction
approaches (only two used a needle
exchange in Ireland). 
■ Promotional material on treatment services was
rarely available in the appropriate language.
■ Some felt uncomfortable with the idea of
'group therapy' where the majority of
participants were Irish.
■ Treatment options were poor, and few
addressed cocaine problems. 
■ Finally, fear of being stigmatised by drug
workers and fear of services reporting a
client’s drug use to the state authorities were
reported as significant barriers. 
This research clearly demonstrates the challenge
facing drug treatment services in the years to
come. As the fieldworkers found, drug users from
new communities were particularly difficult to
reach, and drug treatment services had practically
no knowledge on drug use in new communities.
Only one female drug user from a new community
could be interviewed, raising the question of how
to reach female drug users in new communities. In
addition, it would appear that drug users from
new communities come to Ireland from countries
with little awareness of harm reduction techniques,
therefore the likelihood of their using needle
exchange or low-threshold services is remote.
However, the research concludes with some timely
recommendations on how to make drug services
more accessible to drug users from new
communities. For example: 
■ Drug services need to produce culturally
sensitive material in different languages. 
■ A drugs outreach team should be set up in
Dublin to target drug users from new
communities, using peer-based approaches.
■ Outreach teams should make contact with
female drug users from new communities at
general health promotion and maternity
agencies.
■ Drug services should specifically target
stimulant users.
■ Drug services should recruit staff from new
communities.
■ Anti-racist training should be provided to staff
and clients in drug services.
■ Drug services and the National Drug
Treatment Reporting System (NDTRS) should
include the collection of ethnic-specific data.
(Martin Keane)
1. Merchants Quay Ireland (2004) Drug use among new
communities in Ireland: an exploratory study. Dublin:
National Advisory Committee on Drugs.
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Sixth Annual Service of Commemoration
and Hope
New EMCDDA Director
Ms Sadie Grace, on behalf of the Citywide Family
Support Network, welcomed a large audience to
Our Lady of Lourdes Church in Ballymun on 1
February 2005 for the Sixth Annual Service of
Commemoration and Hope. 
In the course of the evening, much emphasis was
given to the current inadequate recording of drug-
related-deaths in Ireland. The audience heard that,
following the first commemoration service in 2000,
Dr Joe Barry, medical advisor to the National Drugs
Strategy Team had, with the co-operation of
parents, looked at the death certificates of young
people who had died from drug-related causes. It
was found that many of the drug-related deaths
were recorded as death due to misadventure.
A representative group investigated the possibility
of establishing an index to record drug-related
deaths, and in 2003 this group submitted a
proposal to the government. The group consisted
of representatives from Citywide Family Support
Network, Citywide Drugs Crisis Campaign,
Department of Health and Children, Department
of Justice and Dr Joe Barry. Ms Grace announced at
the commemoration service that the group had
just received word that funding had been
sanctioned to establish this index. 
Minister Noel Ahern TD complimented the
ongoing work of the Network and supported the
establishment of the drug-related deaths index. In
his address, Bishop Eamon Walsh said that families
are being neglected; he supported the Network’s
call for a fifth pillar to be added to the National
Drugs Strategy, to deal with issues concerning
families affected by drug misuse.
During the service, family members representing
support groups throughout Ireland, both North
and South, and representatives from Glasgow,
created a circle of support and hope. The musical
talents of the Ballymun Gospel Choir and St
Fergal’s male choir made a powerful and moving
contribution to the service. (Ena Lynn)
Contact for further information: Citywide Family Support
Network, Tel: 01 8365090
On 19 April 2005 Wolfgang Götz (Germany) was
elected to the post of Director of the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). He succeeds Georges Estievenart
(France), whose mandate as Director came to an
end on 31 December 2004 and who headed the
agency since July 1994.
Commenting upon his appointment, Mr Götz said
‘Among my top priorities will be to safeguard and
enhance the scientific quality of our outputs,
demonstrate scientific independence and boost our
reputation as the European centre of excellence in
the drug information field. … Sound information is
the key to an effective strategy on drugs.’
The role of the EMCDDA is to provide the
Community and its member states with objective,
reliable and comparable information at European
level on drugs and drug addiction and their
consequences. It carries out this role in
collaboration with Focal Points (research centres)
in each member state. The Irish Focal Point is the
Drug Misuse Research Division of the Health
Research Board.
Mr Götz joined the EMCDDA in 1996 and from
2001 he was responsible for ‘Reitox and
Enlargement’, where he played a central role with
member states in co-ordinating EMCDDA data-
collection processes and preparing the agency for
the entry of ten new countries in 2004. 
The Drug Misuse Research Division wishes Mr Götz
every success in his new post as Director. (Hamish
Sinclair)
In the course of
the evening,
much emphasis
was given to the
current
inadequate
recording of
drug-related
deaths in Ireland.
The 16th International Conference on the
Reduction of Drug Related Harm was held in
Belfast, Northern Ireland, between 20 and 24
March 2005.  This year the conference
programme was widened to include sessions on
alcohol and tobacco as well as on issues that
typically form the core of International Harm
Reduction Association conferences.  The timetable
for the conference was organised around ten
themes: law enforcement and harm reduction;
prisons; services and treatment; drugs and
injecting; harm reduction practice; non-opiate
drugs; social context and policy responses;
HIV/AIDS and hepatitis C; young people and
education; and harm reduction philosophies and
practice.  The themed approach allowed
participants to follow areas of interest from
among the 84 sessions held over four and a half
days. (Jean Long)
The 16th International Conference on the
Reduction of Drug Related Harm
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Monitoring new trends in drug use
Increasingly, policy makers, service planners,
practitioners and others working in the drugs area
have need of information systems that are sensitive
enough to detect and track changes in drug use at
a very early stage in their development. One
potential source of data on emerging drug trends
is drug helplines.
Since the beginning of 2001 the European
Foundation of Drug Helplines (FESAT) has been
collecting information every six months on the type
of persons contacting FESAT helplines, the content
of these calls and how this has changed compared
to the previous six months. The main objective of
this FESAT monitoring project is to identify new
drugs and new drug trends as early as possible.
In March 2005 FESAT published the results of their
eighth data collection, covering the first six
months of 2004.1 A total of 26 FESAT helplines in
16 European countries, including Ireland,
participated in the eighth monitoring project. This
article will describe some of the main changes that
were reported by the helplines during the first half
of 2004.
Information for the eighth monitoring project was
collected from FESAT helplines using a standard
questionnaire distributed in November 2004. Out
of a total of 41 relevant helplines, 26 (63%
response rate) returned completed questionnaires.
These helplines were based in the following
countries: Austria (3 helplines), Belgium (2),
Cyprus (1), Czech Republic (1), Finland (2),
Germany (2), Greece (3), Ireland (1), Italy (2),
Latvia (1), Luxembourg (1), the Netherlands (2),
Portugal (1), Russia (1), Spain (2) and the United
Kingdom (1). The participating Irish helpline was
the Drugs/HIV Helpline, based in Dublin.
The average number of telephone calls per day to
these helplines varied widely, from less than one to
166 calls per day. The median was 15 daily calls.
The Irish Drugs/HIV Helpline handled an average of
16 calls per day in the first half of 2004, up from 14
per day in the last half of 2003. The category of
drug users for which the largest number of helplines
reported an increased number of contacts
compared to the situation six months ago was that
of drug-using women aged 20–25 years. This was
reported by nearly a third of the helplines (8 out of
26). In terms of the content of the calls, 10 helplines
indicated an increased number of calls about
cocaine. Three of these described this as a ‘large
increase’ compared to the situation six months ago.
An increase in the number of contacts about alcohol
was also reported by 11 helplines. Interestingly,
there was a decrease in the number of contacts
about injecting heroin and ecstasy reported by six
helplines each. Three helplines reported calls about
new drugs (i.e. drugs not previously reported by the
helpline). These were ‘Absint’ in Belgium, ‘Oxanest’
in Finland, and ‘Ayahuasca’ in Portugal.
In summarising the findings, the FESAT report
notes that an increased number of calls about a
specific drug, that is not a part of a more general
trend, cannot automatically be seen as an indicator
of increased consumption. It might also indicate an
increased curiosity or an increased concern among
professionals, parents or partners. The report also
acknowledges that it is not possible to get a clear
picture about changes in the use of different drugs
via data from drug helplines only. Hence, it is
important to see the FESAT monitoring system as a
complement to other kinds of data collected
nationally or internationally.
According to the recently published Drugs/HIV
Helpline Report, the drugs about which most calls
were made to the helpline in 2004 were cannabis
(740 calls), cocaine (427 calls) and heroin (417
calls).2 This was the first year that there were more
calls about cocaine than heroin. Calls related to
cocaine and its use with alcohol increased in 2004
compared with previous years. Of the 427 calls
related to cocaine, 100 (23%) concerned its
combination with alcohol. In 2003, 347 calls
related to cocaine were received, 38 (11%) of
which were identified as being in combination
with alcohol. (Hamish Sinclair)
1. Hibell B (2005) FESAT Monitoring Project -– Changes during
the first half of 2004. FESAT (The European Foundation of
Drug Helplines). www.fesat.org
2. Drugs/HIV Helpline (2005). Drugs/HIV Helpline Report.
Dublin: Drugs/HIV Helpline.
More information about FESAT can be found on
the European Foundation of Drug Helplines at
www.fesat.org
The Drugs/HIV Helpline in Ireland is a confidential,
freephone, active listening service offering non-
directive support, information, guidance and
referral to anyone with a question related to
substance use or HIV and sexual health. Set up in
July 1997, the service is funded and managed by
the Health Service Executive South Western Area
on behalf of the HSE South Western, East Coast
and Northern Areas. The freephone number is
1800 459 459. The Helpline manager is Aileen
Dooley. Ms Dooley’s assistance in writing this
article is gratefully acknowledged.
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Management of Drug Users in the
Primary Care Setting 
Conference held on 12 March 2005 
Among the topics presented at this conference
were: management of benzodiazepine use, drug-
related deaths, and buprenorphine treatment.  In
his welcoming address Dr Finbarr Corkery,
President of the Irish College of General
Practitioners, reiterated the fact that
buprenorphine is now licensed for use in primary
health care settings in Ireland.
Benzodiazepine use
Prof Colin Bradley, Professor of General Practice at
UCC, presented a review of benzodiazepine
prescribing in general practice. He said that
benzodiazepines are difficult to use safely and are
prone to inducing dependence. Analysis of General
Medical Service (GMS) scheme data shows that
benzodiazepines were prescribed for 10 per cent of
the GMS population in 2000.1 Prof Bradley stated
that the Benzodiazepine Commission Report
provides guidelines on good prescribing practice
and protocols for withdrawing patients from these
drugs. International studies have demonstrated
that writing to patients and inviting them to
reduce their benzodiazepine use, with or without
brief interventions, has proven surprisingly effective
in reducing benzodiazepine consumption in some
patients. More challenging cases require tapering
doses with or without cognitive behaviour therapy.
Dr Conor Farren, Consultant Psychiatrist at St
Patrick’s Hospital, outlined the co-abuse of
benzodiazepines in opiate users and the strategies
for management. Both opiates and
benzodiazepines are highly addictive and cause
sedation and respiratory depression. There is a
synergistic interaction between the systems linked
to opiate and benzodiazepine use and a
combination of use may cause increased side
effects. Dr Farren stated that first switching to long-
acting benzodiazepines (such as diazepam), and 
then commencing tapered doses is probably the
most effective benzodiazepine treatment strategy.
Drug-related deaths
Dr Jean Long presented on the epidemiology of
drug-related deaths in Ireland from 1990 to 2002.
She stated that, at present, it is difficult to
ascertain the exact number of deaths among drug
users in Ireland. The best estimate for Dublin
ranges from 60 to 90 deaths per year. However, 
the Family Support Network at Citywide has
indicated to the National Drugs Strategy Team that
these figures underestimate the extent of the
problem. Dr Long outlined the risk profile and risk
factors for drug-related deaths in Ireland:
■ More men than women die; however, there
has been an increase in the number of female
deaths. 
■ The risk of mortality increases with age.
■ Most deaths occur in Dublin, but there is a
steady increase in the number of deaths
outside Dublin
■ Time periods on entry to or exit from prison
have a higher risk than other time periods.
■ The highest proportion of deaths is among
opiate users.
■ Those who use a combination of substances
are more likely to die.
■ Injecting drug use is associated with infection
and overdose.
Dr Long concluded by stating that deaths among
drug users are not systematically documented and
their numbers are likely to be underestimated;
therefore, the introduction of the National Drug-
Related Deaths Index will be very welcome.
Dr Neil O’Brien from the toxicology laboratory in
Beaumount Hospital outlined the recent trends in
post-mortem toxicology. From a study of 679
cases, 312 (46%) had either drugs or alcohol
detected at post-mortem. 
Buprenorphine
Dr Nicholas Lintzeris, Senior Lecturer in Psychiatry
at Maudsley Hospital, London, presented the
evidence base for effective use of buprenorphine:
■ Buprenorphine offers an effective alternative
to methadone.
■ Buprenorphine binds tightly to opiate
receptors and blocks the effects of other
opiates, therefore reducing heroin use. 
■ Buprenorphine is well suited to primary care
settings and comprehensive clinical guidelines
are available.
■ Buprenorphine may become the ‘gold
standard’ for detoxification from opiates.
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From left: Dr Conor Farren (Consultant Psychiatrist),
speaker, Dr Finbarr Corkery (President ICGP), Dr Ide
Delargy (Project Director of ICGP Substance Misuse
Project, speaker, (Prof Colin Bradley (Professor of
General Practice, UCC).  Photo courtesy ICGP
Through its work with researchers, and the range
of valuable information resources it maintains, the
National Documentation Centre on Drug Use
(NDC) makes an important contribution to the
development of knowledge about drug issues.
Over the next few issues of Drugnet Ireland we will
be highlighting some of these resources, which are
available to everyone either online or in the NDC
library.
In this issue we will be looking at:
■ Online databases
■ NDC news service
Online databases in the National
Documentation Centre
The NDC subscribes to a number of online
bibliographic databases.  Visitors to the NDC
library can search these databases with the
assistance of NDC staff.  Bibliographic databases
are essential to any researcher wishing to
undertake a comprehensive literature review or
identify pertinent works in a specific area of study.  
Web of Science databases
The Web of Science comprises three separate
databases that can be searched independently or
in combination.  These databases provide access to
current and retrospective bibliographic
information, author abstracts, and cited references
found in approximately 8,700 journals. 
A unique aspect of the Web of Science is that it
allows cited reference searching.  It is possible to
navigate through the literature, to identify works
which have been cited in a particular article, and
to assess the impact of the article by identifying
those works which have cited it.  The user can
search across all disciplines to identify all the
information relevant to their research, no matter
when it was published.  The three Web of Science
databases are:
■ The Science Citation Index covers over 5,800
journals and is updated by more than 17,000
new records every week.
■ The Social Sciences Citation Index covers over
1,700 journals and is updated by 2,000 new
records every week.
■ The Arts & Humanities Index covers over
1,100 journals and is updated by 2,300 new
records every week.
PsycINFO 
PsycINFO is a bibliographic database that provides
abstracts and citations to literature in the
behavioural science and mental health fields.  It
includes materials in the fields of psychiatry,
psychology, social science, law and medicine, as
well as addiction and drug use.  PsycINFO is
published by the American Psychological
Association and the database is made available to
the NDC through the Ovid platform.  This is a
platform that is widely used by health information
professionals to access databases of relevance to
their work and is easy to use and attractive.  
There are over two million records – bibliographic
details and abstracts – on PsyINFO, with more that 
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■ Treatment with either buprenorphine or
methadone must be tailored to suit the
individual client as each drug has its
advantages and disadvantages.
Dr Tom Gilhooly followed with a presentation on
his practical clinical experiences with
buprenorphine in a drug crisis clinic in Glasgow. In
summary, he has found that:
■ There is little use of buprenorphine in
Scotland.
■ His experience with inpatients has been very
helpful.
■ Patients treated with buprenorphine have
longer opiate-free intervals.
■ Buprenorphine has been useful in treating
codeine dependency.
Dr Ide Delargy, Director of the ICGP Drug Misuse
Programme, speaking about the success of the
conference, said: ‘I am delighted to see so many
delegates, from so many backgrounds, in
attendance today at this our sixth conference on
the management of drug users. The feedback
regarding all of today's presentations has been very 
positive.’ (Ena Lynn)
1. Department of Health and Children (2002) Report of the
Benzodiazepine Committee. Dublin: Stationery Office.
The full text of presentations made to the conference
is available on the ICGP website at www.icgp.ie 
Management of Drug Users in the Primary Care Setting (continued)
National Documentation Centre
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100,000 new records added each year. The database
covers 2,000 titles, 98 per cent of which are peer-
reviewed journals.  PyscINFO also includes chapters
of books and dissertations selected from Dissertations
Abstracts International.  A new edition of PsycINFO
will be launched this summer.  It will make searching
easier and more intuitive.  Another important feature
is Links@Ovid which allows the searcher to move
directly from the bibliographic record to the full text
of the article, if these articles are in journals to which
the NDC subscribes or are in open access journals.
Addiction Abstracts
Addiction Abstracts is published in both serial and
database format.  The serial is published quarterly
and contains citations and abstracts from around
60 core journals specialising in the addiction and
substance use fields.  It regularly scans around 100
other journals in the broader health, education
psychology and social science fields.  The contents
of the current and all back issues of Addiction
Abstracts are available on the database.
NDC News Service
The NDC News service comprises a listing of news
stories, notifications of new publications, and Dáil
debates. It is updated daily. 
News stories
Every day NDC staff scan news stories in national,
local and specialist press, online news sites and
other media to identify topical stories to include in
the news listing.   Each item in the listing contains a
summary of the story and information on its source.
The most recent stories are added to the home
page of the NDC website and all stories are held in
an archive, from where they can be retrieved using
subject headings. There are now 1,800 items in the
news archive going back to early 2002. 
New Publications
The News section of the NDC website also
highlights new publications of interest to people
working in the drugs area.  The notification
includes a link to a copy of the report, if the
publishers have made an electronic copy available.  
Dáil debates
The News section also contains selected content
from current Dáil debates.  Speeches, written
answers and other discussions dealing primarily with
the drugs issue are added in full text to the News
section every two weeks when the Dáil is in session.  
A selection of these news items is included in the
NDC’s monthly electronic newsletter.  You can sign 
up to receive this newsletter on the News page of
the website.
For further information on these resources, or to
make a query on drugs-related topics, plesae
contact the National Documentation Centre on
Drug Use, Health Research Board, Holbrook House,
Holles Street, Dublin 2.  Tel: 01 676 1176; Email:
ndc@hrb.ie or visit the website at www.ndc.hrb.ie. 
If you would like to arrange a group visit to the
NDC, or if you would like a member of the NDC
staff to talk to your class or organisation, please
contact us. (Brian Galvin and Louise Farragher)
The National Documentation Centre on Drug 
Use is funded by the Department of Community,
Rural and Gaeltacht Affairs under the National
Development Plan 2000–2006.
National Documentation Centre (continued)
Damien Walshe
In April Damien Walshe left the National Documentation Centre to
take up a new position with the Irish Traveller Movement.  Damien
made a significant contribution to the development of resources
and services during his two years with the NDC, particularly in the
area of promotion.  Damien’s loquacious, witty and polymathic 
approach to his work endeared him to all staff in the HRB. We 
wish him well in his future career. 
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On 5 February 2005 the Proceeds of Crime
(Amendment) Act 2005 was signed into law. Among
other things, it extends and strengthens the offshore
powers of the Criminal Assets Bureau (CAB) in relation to
the assets of drug dealers. Motions in both Houses of the
Oireachtas to include in the Bill a provision for ring-fencing
the proceeds of drug-related crimes for use in communities
subject to the effects of drug-related crime were defeated.
www.oireachtas.ie   
On 7 February 2005 the Lord Mayor’s Commission on
Crime and Policing in Dublin was released. Based on
submissions received from Dubliners and on the results of
up to 40 focus group meetings, the report discusses public
perceptions of the role of drugs in relation to crime, and
makes recommendations for enhancing responses both by
the Gardaí and public bodies and communities to a range
of issues including the drugs issue. www.dublincity.ie 
On 17 February 2005 the Review of the National Health
Promotion Strategy 2004 was launched. With respect to
the health-promotion topic ‘Avoiding drug misuse’, the
review identified a need to review training in relation to
the Drugs Questions–Local Answers (DQLA) and Family
Communication and Self-Esteem (FCSE) programmes and
develop a monitoring system, and a need to support the
work of the regional drugs task forces.
www.healthpromotion.ie
On 28 February 2005 Social Inclusion is Everyone’s
Business, a socio-economic and demographic study of
Dublin City, was launched. Accompanying the six reports is
a plan outlining an integrated, multi-agency approach to
combating social exclusion among the homeless, Travellers,
lone parents, children at risk (aged 4–10), and
disadvantaged children and youth from newborn to 18
years. www.dublin.ie 
In February 2005 the results of a study on the Criteria
applied by the Courts in Sentencing under s. 15A of the
Misuse of Drugs Act 1977 were released by the
Department of Justice, Equality and Law Reform. The study
concluded that s.15A had operated reasonably successfully.
There was evidence of a high rate of pleas, co-operation by
accused persons with Gardaí in investigating offences, and
quite severe sentences even where the mandatory
minimum sentence had not been imposed, with most
being between six and eight years. www.justice.ie 
In February 2005 EURAD published Issue 1 of its electronic
newsletter. www.eurad.net
On 4 March 2005 the British–Irish Council hosted a
sectoral meeting in Cardiff on the topic of drug-related
deaths. www.britishirishcouncil.org
<http://www.britishirishcouncil
Between 7 and 14 March 2005 the UN’s Commission on
Narcotic Drugs (CND) held its 48th Session in Vienna. The
purpose of the session was to review progress since
UNGASS 1998 (the 20th special session of the UN General
Assembly that adopted three action-oriented resolutions on
drugs, which represented a 10-year action plan
1998–2008) and to determine further work to be done. In
the course of the Session, and activities organised by the
NGO sector, for example the Senlis Council and the
Transnational Institute, the issue of drug-related harm-
reduction – its scope and relation to the UN Conventions –
was widely debated.  www.cnd.org / www.drug-policy.org
/ www.tni.org 
On 19 March 2005 Dáil na nÓg 2005 took place in Croke
Park, Dublin. With regard to alcohol and drug misuse,
delegates highlighted the need for specialised training for
Gardaí on youth issues, more funding for youth-related
activities, and drug and alcohol awareness to be started in
4th class in primary school. The Dáil’s report was to be
presented to the Cabinet Committee on Children.
www.dailnanog.ie 
On 29 March 2005 the National Drugs Strategy Progress
Report 2001–2004 was launched. The report outlines the
background to the Strategy; the nature and extent of drug
misuse in Ireland; progress on actions under the four
pillars; progress on other drug-related initiatives; and future
developments. www.pobail.ie 
In March 2005 the Pharmaceutical Society of Ireland
(PSI) launched its new website. The web site carries a
discussion document on the problem of over-the-counter
(OTC) medicine and codeine product misuse and abuse.
www.pharmaceuticalsociety.ie 
On 14 April 2005 the Irish Sports Council published its
2004 Anti-Doping Annual Report. Of the 918 tests carried
out in 2004, seven positive results were recorded, with five
involving alcohol, cannabis or cocaine. None of the
athletes are named in the report, but from January 2005,
athletes testing positive for recreational drug use will be
named 20 days after their disciplinary process has ended.
www.irishsportscouncil.ie 
On 21 April 2005 the Clondalkin Local Drugs Task Force,
represented by the trade union Impact, won an important
test case in the Labour Court (CD/04/1312
Recommendation No. 18168). The Court recommended
that employees of the Clondalkin LDTF should receive the
benchmarking increases being paid to employees of the
HSE. The employer had argued that it was not possible to
negotiate on the increases due under benchmarking owing
to a lack of funding from the Department of Community,
Rural and Gaeltacht Affairs through the National Drugs
Strategy Team. Moreover, no extra funding would be
provided and if the increase were to be paid from existing
funds, certain other important activities of the LDTF would
have to cease. www.labourcourt.ie
On 21 April 2005 the European Parliament (Committee
for Citizens’ Freedom and Rights, Justice and Home Affairs)
held a public hearing on the EU Drugs Action Plan
2005–2008. The aims of the hearing were (1) to establish
to what extent the Action Plan would reduce the
prevalence of drug use among the population and the
social harm and health damage caused by the use of and
trade in illicit drugs, and (2) to discuss the problems linked
with drug trafficking. www.europarl.eu.int 
(Compiled by Brigid Pike)
In brief
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The EDDRA column
Welcome to the eleventh EDDRA (Exchange on
Drug Demand Reduction Action) column. The aim
of this column is to inform people about the
EDDRA online database, which exists to provide
information on good practice interventions to
policy makers and those working in the drugs area
across Europe, and to promote the role of
evaluation in reducing demand for drugs. The
database is co-ordinated by the European
Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). 
In this issue the spotlight is on a recent Irish
addition to the EDDRA database, the Certificate in
Addiction Studies (NUI Maynooth) delivered by the
Drug Awareness Programme, Crosscare. In recent
years, there has been a notable increase in the
numbers of people from the community and
voluntary sectors working in drug prevention and
treatment. The Addiction Studies course was
designed to meet the needs of these groups who
engage directly with substance users or their
families. The course also caters for those working
in the statutory sector, e.g. probation officers,
teachers etc., who occasionally work with
individuals and families for whom substance use is
an issue. 
The programme has three specific objectives: 
■ To provide participants with a broad overview
of key theoretical frameworks and practical
debates that arise in relation to substance
misuse and dependency
■ To enable participants to develop basic
helping and intervention skills in the field of
drug and alcohol misuse
■ To provide a course of study and support that
is in line with models of good practice in
adult education.
The evaluation of the programme by Dr Mark
Morgan1 commenced in October 2003, when
students completed a questionnaire on their
expectations and experiences of the course thus
far.  The evaluator visited a number of classes and
seminars during the academic year. A final
questionnaire was administered to students at
course completion and participants also took part
in focus groups as the course neared its end. The
evaluation focused primarily on establishing the
extent to which the course (a) contributed to the
professional needs of the community and
voluntary sector, and particularly the participants,
in terms of drug prevention, and (b) was guided
by best practice in the field of adult learning. 
Morgan concluded that feedback from the initial
questionnaire provided reason for course
organisers to be satisfied with their initial work.1
Participants showed knowledge of what they could
learn on the course and what they should learn,
and were confident that they would be able to
learn. They showed realistic expectations, were
confident of the value of the course to their
professional lives and were very positive about the
personal and professional skills of tutors on the
course. 
Twenty students completed questionnaires at the
end of the course. Students regarded most of the
topics covered by the course as satisfactory;
however, some students expressed dissatisfaction
with the pharmacological perspective of the
course.  Students agreed that the course had
enhanced their understanding of addiction and
related issues and had improved their job
prospects to some extent; they had gained insights
into themselves and an understanding of adult
learning.  Seventy-five per cent of students rated as
satisfactory the topics that were designed to
develop their skills base, such as self-care and stress
management, working with specific groups and
working with young people. Thirteen students
deemed the topic of motivational interviewing and
brief solution-focused therapy as satisfactory. 
The evaluation reported that the experiences of
students on the course were extremely positive
and compared favourably with those in other
institutions of higher education. Features of note
were: (a) competency of tutors and lecturers, (b)
class run on model of real adult education, (c) high
level of class discussion on major issues, reflecting
the diverse backgrounds of participants, and (d)
high level of trust within class and between class
and tutors, evidenced by the readiness of people
to disagree with their colleagues. The response of
participants to the work of facilitators was
extremely positive, with facilitators being graded
very highly on approachability, competence,
encouragement and accessibility. 
Morgan concluded the evaluation by summing up
the strengths of this programme: 
It is evident that the Certificate in Addiction
Studies run by the Drug Awareness Programme
has been an outstanding success. The
participants in the course are carefully selected,
highly motivated and eager to be involved in
the course in accordance with a true adult
learning methodology. The content of the
course was well researched and the speakers
for the various topics were extremely
competent, encouraged participation and
showed an enthusiasm for their modules in a
way that was reflected in the very positive
ratings. The assessment procedure was
appropriate to the course and all of the
students were positive about the benefit they
derived from these. (Morgan 2004: 21-22) 
This valuable work carried out by Crosscare is in
part response to Action 72 of the National Drugs
Strategy 2001–2008 calling on professional bodies
and training institutes to make specialist drug
‘The participants
in the course are
carefully selected,
highly motivated
and eager to be
involved in the
course in
accordance with 
a true adult
learning
methodology.’ 
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prevention training available to individuals
interacting with groups most at risk of drug
misuse.  Crosscare is one of the few voluntary
bodies to have responded to this action. (Martin
Keane)
1. Morgan, M (2004) Evaluation of Certificate in Addiction
Studies (NUI Maynooth). Dublin: Crosscare, Drugs
Awareness Programme.
A copy of Dr Morgan’s evaluation can be
downloaded from the Drug Awareness Programme
website at www.dap.ie 
More information about the EDDRA database
can be obtained from the EMCDDA website at
www.emcdda.eu.int , or from the EDDRA
Manager for Ireland, Martin Keane, at the Drug
Misuse Research Division, Health Research Board,
Holbrook House, Holles Street, Dublin 2. Tel: 01
676 1176 Ext.169 or Email: mkeane@hrb.ie
If you would like to contribute to the knowledge
base of good practice interventions by adding
your own particular project to the EDDRA
database, please contact the EDDRA Manager for
Ireland at the above address. 
From Drugnet Europe
Benzodiazepine use among clients in drug
treatment
Cited from Linda Montanari and Iñaki Markez,
Drugnet Europe No. 50, April–June 2005
Currently only a small proportion of Europeans
seeking help for drug problems in specialised drug
treatment centres do so for benzodiazepine use
alone. In 2003, despite differences between
countries, the overall proportion of clients in drug
treatment who reported a primary benzodiazepine
use problem did not exceed 11%, a figure that has
remained stable over the last 10 years.
Treatment clients reporting benzodiazepines as
their primary drug are similar in age to those
reporting opiates as their primary drug (20–29
years). Both groups generally first experiment with
these drugs before the age of 20 but they have
different gender distributions. More women are
present in the group of primary benzodiazepine
users (male to female ratio = 1:1.2) compared with
in the group of primary opiate users (male to
female ratio = 3.8:1). On the whole, both groups
use the drugs daily (82%) often taking them also
as secondary substances in combination with
alcohol and cannabis. Treatment data show
benzodiazepines to be more prominent as a
secondary drug in combination with opiates,
particularly heroin. Between 40% and 90% of
heroin users also consume benzodiazepines.
Evidence for action on needle and syringe
programmes
Cited from ‘Resources’, Drugnet Europe No. 50,
April–June 2005
The World Health Organisation (WHO) has recently
published a comprehensive review on the
effectiveness of sterile needle and syringe
programming (NSP) in reducing HIV/AIDS among
injecting drug users. 
The report summarises the published literature and
scientifically evaluates the results and effectiveness
of studies on needle and syringe programmes. It
examines the value of needle and syringe
decontamination strategies and the sale and
distribution of syringes through pharmacies and
vending machines. It also addresses needle and
syringe disposal and legislation regarding injecting
paraphernalia. The report concludes, among
others, that increasing the availability and
utilisation of sterile injecting equipment by
injecting drug users reduces HIV infection
substantially. 
WHO (2004) Effectiveness of sterile needle and syringe
programming in reducing HIV/AIDS among injecting drug users.
Evidence for Action Technical Papers. Geneva: World Health
Organization. ISBN 92-4-159164-1.
The publication can be ordered from the 
WHO HIV Department hiv-aids@who.int or
downloaded from the WHO website at
www.who.int/hiv/pub/idu/pubidu/en
Drugnet Europe is the quarterly newsletter of
the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA). An electronic
version of Drugnet Europe is available on the
EMCDDA website at www.emcdda.eu.int
If you would like to receive a hard copy of the
current or future issues of Drugnet Europe,
please contact the Administrative Assistant,
Drug Misuse Research Division, Health
Research Board, Holbrook House, Holles
Street, Dublin 2. Tel: 01 676 1176 Ext 127;
Email dmrd@hrb.ie
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Recent publications
Books
Drug abuse
Henderson H (Facts on File, Library in a Book
Series) Facts On File, Inc. 2005
ISBN 0 8160 4858 4
The ‘war on drugs’ has raised many questions
about the nature of the threat, the best ways to
respond, and even whether the chosen tactics
might be doing more harm than good. Drug abuse
explores all aspects of the complex issues raised by
these questions. 
The book is in three parts. The introductory
chapter in Part I outlines the different types of
drugs, how they are used, how they work and why
they can be addictive. It also covers drug
regulation, approaches to treating addiction and
the way drug abuse has shaped public policy.
Chapter 2 gives the history of drug regulation
under state and federal laws and international
agreements and presents a selection of court cases
(mainly from the US Supreme Court) that deal
specifically with drug laws. Further chapters in Part
1 outline the chronology of drug use from 5000
BC to the present and give short biographical
sketches of individuals who have played important
roles on either side of the drug war. Part II is titled
‘A guide to further research’ and contains chapters
on how to research drug abuse issues, an
annotated bibliography, and a listing of US
government and private organisations involved in
the drugs area. Part III comprises five appendices:
Acronyms, Street names, Statistics on abuse and
enforcement, Scheduling of drugs under the
Controlled Substances Act 1970, and the text of
the Supreme Court decision in 2001 in an appeal
case concerning medicinal marijuana.
Altering American consciousness: the history of
alcohol and drug use in the United States,
1800–2000
Tracy SW and Acker CJ (eds) University of
Massachusetts Press 2004 
ISBN 1 55849 425 1 
The introduction to this volume of essays makes
the claim that virtually every American alive has at
some point consumed one, and very likely more
than one, consciousness-altering drug, and that
psychoactive substances have always been an
integral part of American life.  While the use of
drugs is a constant in American history, the way
they have been perceived has varied extensively.
Just as attitudes to tobacco have changed –
cigarettes were seen as ‘coffin nails’ of the early
twenties, became the glamorous accessory of
Hollywood stars in the 1940s, and have latterly
fallen into disfavour as a health risk – so the social
significance of every drug changes over time.
The contributions to this collection explore these
changes, showing how the identity of any
psychoactive substance – from alcohol and nicotine
to cocaine and heroin – owes as much to its users,
their patterns of use, and the cultural context in
which the drug is taken as it does to the drug’s
documented physiological effects.  Rather than
looking at drugs in the mutually exclusive  categories
of licit and illicit drugs, recreational and medicinal
drugs or ‘hard’ and ‘soft drugs, the contributors
challenge readers to consider the ways in which
drugs have shifted historically from one category to
another.  The book is in three parts: Framing
addiction and alcoholism; Alcohol and narcotics in
the American context; and Psychotropics,
psychedelics and cigarettes. The essay topics include:
the rhetoric of addiction; the rhetoric of drug reform;
alcohol consumption among Native Americans; the
dynamics of opiate addiction in the early twentieth
century; the depression era; post World War II; and a
critique of 1950s psychedelic drug research. 
Journal articles 
Smoking and drinking among 15-16 year old
girls: do male peers have an influence?
Curtin M
Irish Journal of Medical Science 2004; 173(4):
191–192
This paper compares the influence of peer
relationships among females in mixed-sex schools
versus single-sex schools on cigarette and alcohol
consumption.A cross sectional study was carried
out in four schools. The information was collected
by means of a questionnaire. Two hundred and
forty-eight questionnaires were completed. Of
those questioned in single-sex schools, 34% had
smoked a cigarette, compared with 61% in mixed-
sex schools (p<0.005). The lifetime prevalence of
alcohol consumption in mixed schools was 88%
compared with 73% in single-sex schools
(p<0.005). This study suggests that females in
mixed-sex schools have a tendency to have earlier
exposure to smoking and alcohol consumption
than girls of the same age in single-sex schools.
Prisoners' views of injecting drug use and harm
reduction in Irish prisons
Long J, Allwright S and Begley C
International Journal of Drug Policy 2004;
15(2):139–149
Drug misuse and hepatitis C are known to be
endemic in Irish prisons. Using a grounded theory
approach, this qualitative study sought to examine
prisoners' views of drug injecting practices and
harm reduction interventions in Dublin prisons.
Thirty-one male prisoners were interviewed (16
injecting drug users and 15 non-injectors). Two
themes relevant to drug use practices emerged.
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Respondents described increased health risks
related to injecting drug use during detention and
associated with a prison environment. These
included: the low availability of heroin, which
encouraged a shift from smoking to injecting; the
scarcity of injecting equipment, which fostered
sharing networks far wider than those outside
prison; inadequate injecting equipment-cleaning
practices; and the rent of needles and syringes in
exchange for the drugs. Both non-injectors and
injectors interviewed supported harm reduction
interventions in prison and felt that the range of
drug services available in prison should mirror
those currently available in the community,
although half opposed or had reservations about
syringe exchange in prison. Prisoners' viewed their
time in prison as an opportunity to address
substance misuse related problems; health
professionals should not miss this opportunity.
Irish injecting drug users and hepatitis C: the
importance of the social context of injecting
Smyth BP, Barry J and Keenan E
International Journal of Epidemiology 2005;
34(1):166–72
The incidence of hepatitis C (HCV) infection
among injecting drug users (IDUs) in Dublin is
particularly high by international standards. The
most robust predictor of an IDU's HCV status is his
or her total number of lifetime injecting episodes.
It has been proposed that participation in specific
unsafe injecting practices is the principal
contributor to this accumulated risk. We sought to
test this hypothesis. The relationship between
social context of injecting and HCV status was also
examined. We conducted a cross-sectional survey
of IDUs recruited from treatment settings in
Dublin. Participants had injected in the preceding
six months and had not previously been tested for
HCV. A structured interview was conducted. HCV
testing was performed on 159 IDUs, and 61%
were antibody positive. The three characteristics
that were significant independent predictors of a
positive test result were: increased total number of
lifetime injecting episodes, closer social
relationships with other IDUs, and injecting in the
home of other IDUs. Frequency of recipient syringe
sharing (i.e. borrowing used syringes from other
IDUs), backloading, and sharing of injecting
paraphernalia were not independently associated
with infection. We found that the robust
association between HCV infection and number of
lifetime injecting episodes was not explained by
increased unsafe injecting practices. The socialized
nature of heroin injecting in Dublin is contributing
to the HCV epidemic in this population. Our
findings suggest that accidental and unnoticed
sharing of injecting equipment may be an
important contributor to an IDU's increasing risk of
infection over time.
Hepatitis C viral clearance in an intravenous
drug-using cohort in the Dublin area
Keating S, Coughlan S, Connell J, Sweeney B and
Keenan E
Irish Journal of Medical Science 2005; 174(1):37–41
The rate of spontaneous HCV viral clearance is
reported as 20—25% but recent data indicate a
higher frequency in some cohorts. The rate of
spontaneous clearance in intravenous drug users
has not been reported in an Irish setting. The aim
of this study was to determine the rate of
spontaneous hepatitis C viral clearance and
genotype in an Irish intravenous drug-using
cohort.  Drug users attending five drug treatment
clinics in the Dublin area were investigated. Data
were prospectively recorded from January 1997 to
June 2001 and follow-up testing completed in
2003. There were 496 HCV antibody-positive
patients identified and assessed for HCV RNA
clearance. All were HIV and hepatitis B negative,
68.8% were male.
HCV RNA negativity (viral clearance) was
documented in 38% of patients. Viral clearance
was 47.4% in females and 34.5% in males (p =
000.6). Clearance was independent of age or
duration of intravenous drug use. Viral clearance,
defined as two negative consecutive HCV RNA
tests, a minimum of one year apart, was sustained
in 82.2% at two-year follow-up, giving an overall
viral clearance of 31.1%. HCV genotype 1 and 3
were most commonly identified at 48.8% and
48.5% respectively in those with chronic infection.
The study concluded that spontaneous HCV viral
clearance occurs at a higher frequency than
previously reported. Genotype 1 and 3 are
commonest in the patient cohort.
Adolescent substance abuse among young
people excluded from school in Belfast
McCrystal P, Higgins K, Percy and Thornton M
Drugs: Education, Prevention & Policy 2005;
12(2):101–112  
The lifestyles of young people excluded from
school have received much attention recently,
particularly in relation to illicit drug use.
Commentators have acknowledged that they
constitute a high-risk group to social disaffection
and substance abuse. This paper reports on a
group of 48 young people living in Belfast aged
13–14 years who are considered to be at a
particularly high risk to substance abuse because
they are excluded from school. The evidence in
this paper suggests that many are already
exhibiting potentially high-risk behaviours to
problem drug use compared with their
contemporaries in mainstream education. This
paper examines the evidence within the context of
a limited existing literature base on this group of
young people. It suggests that a more focused
approach is required for the development of
Recent publications (continued)
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appropriate drug-prevention strategies to meet
their needs. 
Patterns of alcohol consumption in a Northern
Irish sample
McKinney A and Coyle K
Substance Use & Misuse 2005; 40(4):573–579
This paper examines the drinking habits of a
Northern Irish sample during a six-month period in
1998. In addition the study examines the influence
of contextual variables on the quantity and
frequency of alcohol consumption. Questionnaires
were administered to 600 participants; the
response rate was 39.8% (239). An unexpected
low abstinence rate was observed; however, this
may be due to response bias. The results revealed
high frequency (29.7% drink on four or more days
a week) and high quantity of alcohol consumption
(mean units per week 43.21, SD 40.33). Beer
drinkers consumed the largest quantity of alcohol
and also had the highest frequency of alcohol
consumption. It was observed that 45.8% of all
drinking events took place in a public bar and the
popularity of the public bar for alcohol
consumption was not influenced by age or gender.
The present investigation revealed that almost half
(45%) of individuals consume more than one type
of beverage at one sitting, and there is a trend of
consuming alcohol in more than one place during
a single drinking session. These results indicate a
distinctive drinking pattern within Northern Ireland
and have implications for studies investigating the
effects of alcohol on the social drinker.
Upcoming events
June
23 June 2005
Employee Drug Testing: Complying with the
Proposed Safety, Health and Welfare at Work
Bill 2004
Venue: Hodson Bay Hotel, Athlone, Co Meath
Organised by / Contact: Caroline Cahill, EAP
Institute, 143 Barrack Street, Waterford
Tel: +353 (0) 51 855733
Fax: +353 (0) 51 879626
Email: eapinstitute@eircom.net
29 June 2005
Sentenced to Treatment – Meeting the Needs of
Drug Using Offenders
Venue: Hamilton House, London
Organised by / Contact: Sunita Patel (Events
Organiser), Centre for Crime and Justice Studies
Tel: +44 (0) 207 848 1688
Email: sunita.patel@kcl.ac.uk
www.kcl.ac.uk/depsta/rel/ccjs
Information: A one-day conference in London,
looking at the recent developments in terms of
drug treatment provisions in the criminal justice
system. This practice-focused event aims to
highlight for drug treatment agencies and
practitioners the implications of the increase in
referrals coming through the criminal justice route. 
30 June 2005
Residential Drug Services: Where do they fit on
the Treatment Map?
Venue: Shaftesbury House, 5 Waterloo Street,
Glasgow 
Organised by / Contact: Lyn Stirling, Scottish
Drugs Forum 
Tel: +44 (0) 141 221 1175
Email: Lyn@sdf.org.uk
www.sdf.org.uk
Information: This one-day event will look at
residential services in Scotland, examining their
current role in treatment and considering how
their contribution to addressing drug use in
Scotland might be optimised. Speakers include
Nicolas Heller, Basel, Switzerland; Dr Stefan
Janikiewicz, of Wirral Drug Service in Cheshire;
Dawn Griesbach, Substance Misuse Division,
Scottish Executive; Valerie Corbett, Aberlour
Childcare Trust; and Penny Halliday, Scottish
Network of Families Affected by Drugs. 
July
7–8 July 2005
Criminal Justice and Drugs
Venue: Ashford International Hotel, Ashford, Kent
Organised by / Contact: Pavilion
Tel: +44 (0) 870 161 3505
www.pavpub.com
Information: The development of the Drug
Interventions Programme (DIP), the merging of
probation in prisons into the National Offender
Management Service (NOMS) and new teams
being created will all put increasing pressure on the
multi-agency approach to drug-related offences in
the context of implementation of the 2003
Criminal Justice Act. This groundbreaking national
conference will provide an opportunity to reflect on
the implications of the changes on offer and
provide practical solutions of innovation. In
particular a major theme will be to consider how
such practices are developed in other European
countries and what we might take from their
expertise.
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7–9 July 2005
8th European Conference on Drugs and Infections in Prison.
Unlocking Potential – Making Prisons Safe for Everyone
Venue: Corinthia Grand Hotel Royal, Budapest, Hungary
Organised by / Contact: Cranstoun Drug Services, European
Network on Drug and Infections Prevention in Prison (ENDIPP)
and others. Contact Salma Master, Cranstoun Drug Services
Tel: +44 (0) 208 5438333 
Fax: +44 (0) 208 5434348
Email: smaster@cranstoun.org.uk
Information: This year's event will cover a range of topics,
including: though-care and after care; multi-agency working in
practice; and harm reduction. The main focus will concern work
directly within prisons, however previous events have
demonstrated that having contributions from those involved in
the criminal justice process and health services outside of prisons
gives a more balanced perspective in considering prisons as part
of the communities they serve, able to impact on these
communities in a positive way. The conference will continue this
approach, with the range of contributors reflecting the broadest
possible constituency. 
September
19-21 September 2005
International Symposium on Substance Abuse Treatment.
Transatlantic Forum on Drug and Alcohol Problems
Venue: Floréal Club Congress Centre, Belgium
Organised by / Contact: This event is a joint organisation of
the Department of Orthopedagogics (Ghent University, Belgium)
and the Ohio Institute for Addiction Studies (Ohio, US) in close
collaboration with the Scottish Addiction Studies Group
(Department of Applied Social Sciences, University of Stirling,
Scotland), the European Working Group on Drug Oriented
Research (EWODOR), the European Federation of Therapeutic
Communities (EFTC) and the Association for Alcohol and other
Drug Problems (VAD, Belgium). Contact Kathy Colpaert
Tel: +32 9 264 64 76
Fax: +32 9 264 64 91
Email: Kathy.Colpaert@UGent.be
Information: The objectives of this year’s symposium are to
exchange expertise and to foster the relationships between
European and North American professionals, researchers and
policy makers in the field of substance abuse treatment,
specifically in three areas:
■ National and international policies on drug and alcohol
problems
■ Treatment and prevention approaches to drug and alcohol
abuse
■ Alcohol, drugs and the law
October
23–28 October
48th ICAA Conference on Dependencies
Venue: Corinthia Grand Hotel Royal, Budapest, Hungary
Organised by / Contact: International Council on Alcohol and
Addictions
Tel: + 36 70 452 0022
Email: budapestoffice@icaa.hu
www.icaa.ch
Information: At this year's conference, entitled 'Science, Politics
and Practitioners', delegates will hear from leading figures in the
field from across the globe. Topics include: policy evaluation;
substance use and addictive behaviour in the lifecycle; service
quality; implementation of multi-pillar policies; the economic
realities, political priorities and the future of services. 
Drugnet Ireland mailing list
If you wish to have your name included on the mailing list
for future issues of Drugnet Ireland, please send your
contact details to the Administrative Assistant, Drug
Misuse Research Division, Health Research Board,
Holbrook House, Holles Street, Dublin 2. Tel: 01 676 1176
Ext 127; Email: dmrd@hrb.ie
Please indicate if you would also like to be included in the
mailing list for Drugnet Europe and Drugs in focus
The documents referred to in this issue of Drugnet Ireland
are available in the National Documentation Centre on
Drug Use at the above address. Tel: 676 1176 Ext 175;
Email ndc@hrb.ie
The Drug Misuse Research Division (DMRD) of the Health
Research Board is a multi-disciplinary team of researchers
and information specialists who provide objective, reliable
and comparable information on the drug situation, its
consequence and responses in Ireland. The DMRD
maintains two national drug-related surveillance systems
and is the national focal point for the European
Monitoring Centre for Drugs and Drug Addiction. The
Division also manages the National Documentation Centre
on Drug Use. The DMRD disseminates research findings,
information and news through its quarterly newsletter,
Drugnet Ireland, and other publications. Through its
activities, the DMRD aims to inform policy and practice in
relation to drug use.
